Why I Won't Vax Home I Don't Trust Big Pharma Conflicts of Interest No Liability The Vaccine Inserts Inadequate Safety Testing Ingredients The Risks Outweigh The Benefit Unvaxxed are Healthier Decline in Illness Prior to Vaccines Vaccine Failure & Shedding Autism Vaccines Dont Cause Autism Vaccines Do Cause Autism Search Results BACK TO INGREDIENTS Polysorbate 80 Dietary emulsifiers consumption alters anxiety-like and social-related behaviors in mice in a sex-dependent manner Holder MK, Peters NV, Whylings J, Fields CT, Gewirtz AT, Chassaing B, de Vries GJ. Dietary emulsifiers consumption alters anxiety-like and social-related behaviors in mice in a sex-dependent manner. Sci Rep. 2019 Jan 17;9(1):172. doi: 10.1038/s41598-018-36890-3. PMID: 30655577; PMCID: PMC6336787. Dietary emulsifiers carboxylmethylcellulose (CMC) and polysorbate 80 (P80) alter the composition of the intestinal microbiota and induce chronic low-grade inflammation, ultimately leading to metabolic dysregulations in mice. Importantly, emulsifier treatment altered anxiety-like behaviors in males and reduced social behavior in females. It also changed expression of neuropeptides implicated in the modulation of feeding as well as social and anxiety-related behaviors. Read More Polysorbate 80 increases the susceptibility to oxidative stress in rat thymocytes Tatsuishi T, Oyama Y, Iwase K, Yamaguchi JY, Kobayashi M, Nishimura Y, Kanada A, Hirama S. Polysorbate 80 increases the susceptibility to oxidative stress in rat thymocytes. Toxicology. 2005 Feb 1;207(1):7-14. doi: 10.1016/j.tox.2004.07.020. PMID: 15590117. Polysorbate 80 at clinically-relevant concentrations increases the cytotoxicity of hydrogen peroxide under the in vitro condition. Result suggests that polysorbate 80 may increase the susceptibility of cells to oxidative stress. Read More Dual effects of Tween 80 on protein stability Wang W, Wang YJ, Wang DQ. Dual effects of Tween 80 on protein stability. Int J Pharm. 2008 Jan 22;347(1-2):31-8. doi: 10.1016/j.ijpharm.2007.06.042. Epub 2007 Jul 3. PMID: 17692480. Tween 80 increased the rate of oxidation in general but also altered the temperature-dependency of IL-2 mutein oxidation. Read More Polysorbate 80-induced leaky gut impairs skeletal muscle metabolism in mice Nishimura S, Aoi W, Kodani H, Kobayashi Y, Wada S, Kuwahata M, Higashi A. results suggest that daily PS80 intake induces intestinal permeability, leading to glucose intolerance and mitochondrial dysfunction in the skeletal muscle. Read More Consumption of Select Dietary Emulsifiers Exacerbates the Development of Spontaneous Intestinal Adenoma Viennois E, Chassaing B. Consumption of Select Dietary Emulsifiers Exacerbates the Development of Spontaneous Intestinal Adenoma. Int J Mol Sci. 2021 Mar 5;22(5):2602. doi: 10.3390/ijms22052602. PMID: 33807577; PMCID: PMC7961571. Overall, our findings further support the hypothesis that emulsifier consumption may be a new modifiable risk factor for colorectal cancer (CRC) and that alterations in host-microbiota interactions can favor gastrointestinal carcinogenesis in individuals with a genetical predisposition to such disorders. Read More Polysorbate-80 modified neurotoxin nanoparticle with its transport and cytotoxicity against blood-brain barrier Zhao YM, Xia AX, Wei YH, Ruan YP, Li FZ. [Polysorbate-80 modified neurotoxin nanoparticle with its transport and cytotoxicity against blood-brain barrier]. Yao Xue Xue Bao. 2010 Oct;45(10):1312-6. Chinese. PMID: 21348312. polysorbate-80 modified neurotoxin nanoparticles can transport across the BBB Read More Dietary emulsifier polysorbate-80-induced small-intestinal vulnerability to indomethacin-induced lesions via dysbiosis Furuhashi H, Higashiyama M, Okada Y, Kurihara C, Wada A, Horiuchi K, Hanawa Y, Mizoguchi A, Nishii S, Inaba K, Sugihara N, Watanabe C, Komoto S, Tomita K, Miura S, Hokari R. Polysorbate-80 enhances the vulnerability of the small intestine to indomethacin-induced injury by inducing ileal dysbiosis. Direct enhancement of the motility of specific flagellated microbiota by P80 might be related to dysbiosis and intestinal injury. Read More Flow-cytometric analysis on adverse effects of polysorbate 80 in rat thymocytes Hirama S, Tatsuishi T, Iwase K, Nakao H, Umebayashi C, Nishizaki Y, Kobayashi M, Ishida S, Okano Y, Oyama Y. Polysorbate 80 increases membrane permeability and decreased glutathione content. Read More Dietary Emulsifier-Induced Low-Grade Inflammation Promotes Colon Carcinogenesis Viennois E, Merlin D, Gewirtz AT, Chassaing B. Dietary Emulsifier-Induced Low-Grade Inflammation Promotes Colon Carcinogenesis. Cancer Res. 2017 Jan 1;77(1):27-40. doi: 10.1158/0008-5472.CAN-16-1359. Epub 2016 Nov 7. PMID: 27821485; PMCID: PMC5214513. Here, we demonstrate in a preclinical model of colitis-induced colorectal cancer that regular consumption of dietary emulsifiers, carboxymethylcellulose or polysorbate-80, exacerbated tumor development. Enhanced tumor development was associated with an altered microbiota metagenome characterized by elevated levels of lipopolysaccharide and flagellin Read More Preparation and therapeutic efficacy of polysorbate-80-coated amphotericin B/PLA-b-PEG nanoparticles Ren T, Xu N, Cao C, Yuan W, Yu X, Chen J, Ren J. Preparation and therapeutic efficacy of polysorbate-80-coated amphotericin B/PLA-b-PEG nanoparticles. J Biomater Sci Polym Ed. 2009;20(10):1369-80. doi: 10.1163/092050609X12457418779185. PMID: 19622277. The prepared nanoparticles were spherical with homogeneous distribution. Drug concentration in mice brain was greatly enhanced, which indicated that the coated nanoparticles could get across the BBB Read More Macromolecules in polysorbate 80 for injection: an important cause of anaphylactoid reactions Li Y, Duan J, Xia H, Li Y, Shu B, Duan W. macromolecular impurities may cause strong anaphylactoid reactions, passive cutaneous anaphylactoid (PCA) reactions, pulmonary capillary permeability, vasodilation, and severe hemolysis Read More Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome Chassaing B, Koren O, Goodrich JK, Poole AC, Srinivasan S, Ley RE, Gewirtz AT. relatively low concentrations of two commonly used emulsifiers, namely carboxymethylcellulose and polysorbate-80, induced low-grade inflammation and obesity/metabolic syndrome in wild-type hosts and promoted robust colitis in mice predisposed to this disorder. Emulsifier-induced metabolic syndrome was associated with microbiota encroachment, altered species composition and increased pro-inflammatory potential. Read More

Why I Won't Vax Home I Don't Trust Big Pharma Conflicts of Interest No Liability The Vaccine Inserts Inadequate Safety Testing Ingredients The Risks Outweigh The Benefit Unvaxxed are Healthier Decline in Illness Prior to Vaccines Vaccine Failure & Shedding Autism Vaccines Dont Cause Autism Vaccines Do Cause Autism Search Results Return to Ingredients Aluminum Do aluminum vaccine adjuvants contribute to the rising prevalence of autism? Tomljenovic L, Shaw CA. Do aluminum vaccine adjuvants contribute to the rising prevalence of autism? J Inorg Biochem. 2011 Nov;105(11):1489-99. doi: 10.1016/j.jinorgbio.2011.08.008. Epub 2011 Aug 23. PMID: 22099159. Our results show that: (i) children from countries with the highest ASD prevalence appear to have the highest exposure to Al from vaccines; (ii) the increase in exposure to Al adjuvants significantly correlates with the increase in ASD prevalence in the United States observed over the last two decades Read More Empirical Data Confirm Autism Symptoms Related to Aluminum and Acetaminophen Exposure Seneff, S.; Davidson, R.M.; Liu, J. Empirical Data Confirm Autism Symptoms Related to Aluminum and Acetaminophen Exposure. Entropy 2012, 14, 2227-2253. https://doi.org/10.3390/e14112227 In this paper, we have presented some analyses of the VAERS database which strongly suggest that the aluminum in vaccines is toxic to vulnerable children. While we have not shown that aluminum is directly causative in autism, the compelling evidence available from the literature on the toxicity of aluminum, combined with the evidence we present for severe adverse reactions occurring much more frequently following administration of aluminum-containing vaccines as compared to non-aluminum-containing vaccines, suggests that neuronal damage due to aluminum penetration into the nervous system may be a significant factor in autism. Read More Experimental Epilepsy in the Monkey Following Multiple Intracerebral Injections of Alumina Cream Joseph G. Chusid, Lenore M. Kopeloff, Ph.D. and Nicholas Kopeloff, Ph.D. The Bulletin, 1953. Aluminum caused tics and grand mal seizures in monkeys. Read More Macrophagic myofasciitis lesions assess long-term persistence of vaccine derived aluminum hydroxide in muscle R.K. Gherardi, M. Coquet, P. Cherin, L. Belec, P. Moretto, P.A. Dreyfus. Brain, 2001, 124, 1821-1831. French scientists tie aluminum adjuvant in vaccine to macrophagic myofasciitis. Read More Long-term persistence of vaccine-derived aluminum hydroxide is associated with chronic cognitive dysfunction Maryline Couette, Marie-Françoise Boisse, Patrick Maison, Pierre Brugieres, Pierre Cesaro, Xavier Chevalier, Romain K. Gherardi, Anne-Catherine Bachoud-Levi, François-Jérôme Authier. Journal of Inorganic Biochemistry, 2009. French scientists report aluminum from vaccines causes chronic cognitive dysfunction. Read More Aluminum in the central nervous system (CNS): toxicity in humans and animals, vaccine adjuvants, and autoimmunity Shaw C, Tomljenovic L. Immunologic Research. 2013;56:304–316. Canadian researchers: aluminum in vaccines can cause both autoimmunity and neurological damage. Read More Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: Unveiling the pathogenic, clinical and diagnostic aspects Perricone C, Colafrancesco S, Mazor RD, Soriano A, Agmon-Levin N, Shoenfeld Y. Journal of Autoimmunity. 2013;47:1-16. Israeli and Italian researchers demonstrate that exposure to aluminum in vaccines can lead to autoimmune and brain dysfunction. Read More Aluminum exposure and toxicity in neonates: a practical guide to halt aluminum overload in the prenatal and perinatal periods. Fanni D, et al. World Journal of Pediatrics, 2014 May; 10(2):101-7. Newborns have been overexposed to aluminum. Read More Neuroprotective effect of Allium cepa L. in aluminium chloride induced neurotoxicity Tanveer Singh and Rajesh Kumar Goel. NeuroToxicology, 49 (2015) 1–7. Chronic aluminium administration resulted in significant motor incoordination and memory deficits, which were also endorsed biochemically as there was increased oxidative stress as well as elevated aluminium levels in the brain. Read More Assessment of hair aluminum, lead, and mercury in a sample of autistic Egyptian children: Environmental risk factors of heavy metals in autism El Baz Mohamed F, Zaky EA, Bassuoni EI-Sayed A, et al. Behavioural Neurology. 2015, Article ID 545674. Autistic children accumulate metals at a much higher level than children who do not have a diagnosis of autism. Read More On vaccine’s adjuvants and autoimmunity: Current evidence and future perspectives Pellegrino P, Clementi E, Radice S. Autoimmunity Reviews. 2015;14(10):880-888. The specific mechanism of action of each vaccine adjuvant may have different effects on the course of autoimmune conditions resulting from vaccination Read More Aluminum in Childhood Vaccines Is Unsafe Neil Z. Miller. Journal of American Physicians and Surgeons, Winter 2016. Aluminum in vaccines is highly neurotoxic and exposure levels given to infants have dramatically increased. Read More Behavioral abnormalities in female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil Inbar R, Weiss R, Tomljenovic L, Arango M-T, Deri Y, Shaw CA, Chapman J, Blank M, Shoenfeld Y. Immunologic Research. 2017;65(1):136-149. Israeli, Canadian and Colombian scientists show that the Gardasil vaccine triggers brain inflammation and autoimmunity in mice. Read More Combined subchronic toxicity of aluminum (III), titanium (IV) and silicon (IV) oxide nanoparticles and its alleviation with a complex of bioprotectors IA Minigalieva, BA Katsnelson, LI Privalova, et al. International Journal of Molecular Sciences, March 2018;19(3):837. Aluminum nanoparticles are toxic on their own and in combination with other metal nanoparticles. Read More Synergism in aluminum and mercury neurotoxicity Peter N Alexandrov,1 Aileen I Pogue,2 and Walter J Lukiw Aluminum and mercury sulfates may contribute to neurodegeneration and progressive age-related functional decline such as Alzheimer’s disease. Read More Reconsideration of the immunotherapeutic pediatric safe dose levels of aluminum James Lyons-Weiler 1, Robert Ricketson 2 The levels of aluminum present in individual vaccines and in the modern vaccine schedule as a whole are problematically high. Read More Aluminium in brain tissue in multiple sclerosis Matthew Mold,1 Agata Chmielecka,2 Maria Raquel Ramirez Rodriguez,1 Femia Thom,2 Caroline Linhart,3 Andrew King,4 and Christopher Exley1,* The first-ever measurements of aluminum in the brain tissue of donors with multiple sclerosis detected pathologically significant levels of aluminum in every single individual. Read More Immunoexcitotoxicity as the central mechanism of etiopathology and treatment of autism spectrum disorders: a possible role of fluoride and aluminum Strunecka A, Blaylock RL, Patocka J, Strunecky O. Surgical Neurology International. 2018;9:74. Fluoride and aluminum, alone or in combination, can produce the condition of “immunoexcitotoxicity” that leads to the pathological changes seen in autism. Read More Unraveling the enigma: elucidating the relationship between the physicochemical properties of aluminium-based adjuvants and their immunological mechanisms of action Emma Shardlow, Matthew Mold & Christopher Exley Aluminum adjuvants in vaccines produce toxic effects ranging from benign to fatal, depending on the physicochemical properties of the adjuvant and the physiological response of the vaccine recipient. Read More Aluminium toxicosis: a review of toxic actions and effects Ikechukwu Onyebuchi Igbokwe, Ephraim Igwenagu, Nanacha Afifi Igbokwe. Interdiscip Toxicol. 2019; Vol. 12(2): 45–70. doi: 10.2478/intox-2019-0007 With the preliminary literature search starting in 2013 and looking backwards in time, research publications revealed a myriad of toxic actions of Aluminum causing pathological conditions. Read More Acute exposure and chronic retention of aluminum in three vaccine schedules and effects of genetic and environmental variation Journal of Trace Elements in Medicine and Biology Among the three schedules presented here, the CDC schedule exceeds the recommended dose limit for an infant (inferred from FDA adult “safe” levels) as a result of the simultaneous administration of multiple ACVs and insufficient spacing of ACVs. Read More Imaging of aluminium and amyloid β in neurodegenerative disease Christopher Exley∗ and Matthew J. Mold We suggest that complementary aluminium-specific fluorescence microscopy may reveal important information about the putative toxicity of aluminium in neurodegenerative and neurodevelopmental disorders. Read More Association Between Aluminum Exposure From Vaccines Before Age 24 Months and Persistent Asthma at Age 24 to 59 Months Academic Pediatrics In a large observational study, a positive association was found between vaccine-related aluminum exposure and persistent asthma. While recognizing the small effect sizes identified and the potential for residual confounding, additional investigation of this hypothesis appears warranted. Read More Aluminum and Alzheimer's Disease: After a Century of Controversy, Is there a Plausible Link? IOS Press The hypothesis that Al significantly contributes to AD is built upon very solid experimental evidence and should not be dismissed. Immediate steps should be taken to lessen human exposure to Al, which may be the single most aggravating and avoidable factor related to AD. Read More Aluminum adjuvant linked to gulf war illness induces motor neuron death in mice Springer The findings suggest a possible role for the aluminum adjuvant in some neurological features associated with GWI and possibly an additional role for the combination of adjuvants. Read More Administration of aluminium to neonatal mice in vaccine-relevant amounts is associated with adverse long term neurological outcomes Journal of Inorganic Biochemistry Repetitive administration of aluminium to neonatal mice in amounts comparable to those to children receive via routine vaccinations significantly increases anxiety and reduces exploratory behaviour and locomotor activities. The neurodisruptive effects of aluminium are long-lasting and persist for 6 months following injection. Read More STUDY: CDC VACCINE SCHEDULE LIKELY INDUCES ALUMINUM TOXICITY IN NEWBORNS Jefferey Jaxen A new study published in the Journal of Trace Elements in Medicine and Biology concluded the U.S. Centers for Disease Control and Prevention’s (CDC) vaccine schedule was 15.9 times over the recommended safe level of aluminum when researchers adjusted for body weight. Read More

Why I Won't Vax Home I Don't Trust Big Pharma Conflicts of Interest No Liability The Vaccine Inserts Inadequate Safety Testing Ingredients The Risks Outweigh The Benefit Unvaxxed are Healthier Decline in Illness Prior to Vaccines Vaccine Failure & Shedding Autism Vaccines Dont Cause Autism Vaccines Do Cause Autism Search Results BACK TO INGREDIENTS Polysorbate 80 Dietary emulsifiers consumption alters anxiety-like and social-related behaviors in mice in a sex-dependent manner Holder MK, Peters NV, Whylings J, Fields CT, Gewirtz AT, Chassaing B, de Vries GJ. Dietary emulsifiers consumption alters anxiety-like and social-related behaviors in mice in a sex-dependent manner. Sci Rep. 2019 Jan 17;9(1):172. doi: 10.1038/s41598-018-36890-3. PMID: 30655577; PMCID: PMC6336787. Dietary emulsifiers carboxylmethylcellulose (CMC) and polysorbate 80 (P80) alter the composition of the intestinal microbiota and induce chronic low-grade inflammation, ultimately leading to metabolic dysregulations in mice. Importantly, emulsifier treatment altered anxiety-like behaviors in males and reduced social behavior in females. It also changed expression of neuropeptides implicated in the modulation of feeding as well as social and anxiety-related behaviors. Read More Polysorbate 80 increases the susceptibility to oxidative stress in rat thymocytes Tatsuishi T, Oyama Y, Iwase K, Yamaguchi JY, Kobayashi M, Nishimura Y, Kanada A, Hirama S. Polysorbate 80 increases the susceptibility to oxidative stress in rat thymocytes. Toxicology. 2005 Feb 1;207(1):7-14. doi: 10.1016/j.tox.2004.07.020. PMID: 15590117. Polysorbate 80 at clinically-relevant concentrations increases the cytotoxicity of hydrogen peroxide under the in vitro condition. Result suggests that polysorbate 80 may increase the susceptibility of cells to oxidative stress. Read More Dual effects of Tween 80 on protein stability Wang W, Wang YJ, Wang DQ. Dual effects of Tween 80 on protein stability. Int J Pharm. 2008 Jan 22;347(1-2):31-8. doi: 10.1016/j.ijpharm.2007.06.042. Epub 2007 Jul 3. PMID: 17692480. Tween 80 increased the rate of oxidation in general but also altered the temperature-dependency of IL-2 mutein oxidation. Read More Polysorbate 80-induced leaky gut impairs skeletal muscle metabolism in mice Nishimura S, Aoi W, Kodani H, Kobayashi Y, Wada S, Kuwahata M, Higashi A. results suggest that daily PS80 intake induces intestinal permeability, leading to glucose intolerance and mitochondrial dysfunction in the skeletal muscle. Read More Consumption of Select Dietary Emulsifiers Exacerbates the Development of Spontaneous Intestinal Adenoma Viennois E, Chassaing B. Consumption of Select Dietary Emulsifiers Exacerbates the Development of Spontaneous Intestinal Adenoma. Int J Mol Sci. 2021 Mar 5;22(5):2602. doi: 10.3390/ijms22052602. PMID: 33807577; PMCID: PMC7961571. Overall, our findings further support the hypothesis that emulsifier consumption may be a new modifiable risk factor for colorectal cancer (CRC) and that alterations in host-microbiota interactions can favor gastrointestinal carcinogenesis in individuals with a genetical predisposition to such disorders. Read More Polysorbate-80 modified neurotoxin nanoparticle with its transport and cytotoxicity against blood-brain barrier Zhao YM, Xia AX, Wei YH, Ruan YP, Li FZ. [Polysorbate-80 modified neurotoxin nanoparticle with its transport and cytotoxicity against blood-brain barrier]. Yao Xue Xue Bao. 2010 Oct;45(10):1312-6. Chinese. PMID: 21348312. polysorbate-80 modified neurotoxin nanoparticles can transport across the BBB Read More Dietary emulsifier polysorbate-80-induced small-intestinal vulnerability to indomethacin-induced lesions via dysbiosis Furuhashi H, Higashiyama M, Okada Y, Kurihara C, Wada A, Horiuchi K, Hanawa Y, Mizoguchi A, Nishii S, Inaba K, Sugihara N, Watanabe C, Komoto S, Tomita K, Miura S, Hokari R. Polysorbate-80 enhances the vulnerability of the small intestine to indomethacin-induced injury by inducing ileal dysbiosis. Direct enhancement of the motility of specific flagellated microbiota by P80 might be related to dysbiosis and intestinal injury. Read More Flow-cytometric analysis on adverse effects of polysorbate 80 in rat thymocytes Hirama S, Tatsuishi T, Iwase K, Nakao H, Umebayashi C, Nishizaki Y, Kobayashi M, Ishida S, Okano Y, Oyama Y. Polysorbate 80 increases membrane permeability and decreased glutathione content. Read More Dietary Emulsifier-Induced Low-Grade Inflammation Promotes Colon Carcinogenesis Viennois E, Merlin D, Gewirtz AT, Chassaing B. Dietary Emulsifier-Induced Low-Grade Inflammation Promotes Colon Carcinogenesis. Cancer Res. 2017 Jan 1;77(1):27-40. doi: 10.1158/0008-5472.CAN-16-1359. Epub 2016 Nov 7. PMID: 27821485; PMCID: PMC5214513. Here, we demonstrate in a preclinical model of colitis-induced colorectal cancer that regular consumption of dietary emulsifiers, carboxymethylcellulose or polysorbate-80, exacerbated tumor development. Enhanced tumor development was associated with an altered microbiota metagenome characterized by elevated levels of lipopolysaccharide and flagellin Read More Preparation and therapeutic efficacy of polysorbate-80-coated amphotericin B/PLA-b-PEG nanoparticles Ren T, Xu N, Cao C, Yuan W, Yu X, Chen J, Ren J. Preparation and therapeutic efficacy of polysorbate-80-coated amphotericin B/PLA-b-PEG nanoparticles. J Biomater Sci Polym Ed. 2009;20(10):1369-80. doi: 10.1163/092050609X12457418779185. PMID: 19622277. The prepared nanoparticles were spherical with homogeneous distribution. Drug concentration in mice brain was greatly enhanced, which indicated that the coated nanoparticles could get across the BBB Read More Macromolecules in polysorbate 80 for injection: an important cause of anaphylactoid reactions Li Y, Duan J, Xia H, Li Y, Shu B, Duan W. macromolecular impurities may cause strong anaphylactoid reactions, passive cutaneous anaphylactoid (PCA) reactions, pulmonary capillary permeability, vasodilation, and severe hemolysis Read More Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome Chassaing B, Koren O, Goodrich JK, Poole AC, Srinivasan S, Ley RE, Gewirtz AT. relatively low concentrations of two commonly used emulsifiers, namely carboxymethylcellulose and polysorbate-80, induced low-grade inflammation and obesity/metabolic syndrome in wild-type hosts and promoted robust colitis in mice predisposed to this disorder. Emulsifier-induced metabolic syndrome was associated with microbiota encroachment, altered species composition and increased pro-inflammatory potential. Read More

Why I Won't Vax Home I Don't Trust Big Pharma Conflicts of Interest No Liability The Vaccine Inserts Inadequate Safety Testing Ingredients The Risks Outweigh The Benefit Unvaxxed are Healthier Decline in Illness Prior to Vaccines Vaccine Failure & Shedding Autism Vaccines Dont Cause Autism Vaccines Do Cause Autism Search Results Return to Ingredients Aluminum Do aluminum vaccine adjuvants contribute to the rising prevalence of autism? Tomljenovic L, Shaw CA. Do aluminum vaccine adjuvants contribute to the rising prevalence of autism? J Inorg Biochem. 2011 Nov;105(11):1489-99. doi: 10.1016/j.jinorgbio.2011.08.008. Epub 2011 Aug 23. PMID: 22099159. Our results show that: (i) children from countries with the highest ASD prevalence appear to have the highest exposure to Al from vaccines; (ii) the increase in exposure to Al adjuvants significantly correlates with the increase in ASD prevalence in the United States observed over the last two decades Read More Empirical Data Confirm Autism Symptoms Related to Aluminum and Acetaminophen Exposure Seneff, S.; Davidson, R.M.; Liu, J. Empirical Data Confirm Autism Symptoms Related to Aluminum and Acetaminophen Exposure. Entropy 2012, 14, 2227-2253. https://doi.org/10.3390/e14112227 In this paper, we have presented some analyses of the VAERS database which strongly suggest that the aluminum in vaccines is toxic to vulnerable children. While we have not shown that aluminum is directly causative in autism, the compelling evidence available from the literature on the toxicity of aluminum, combined with the evidence we present for severe adverse reactions occurring much more frequently following administration of aluminum-containing vaccines as compared to non-aluminum-containing vaccines, suggests that neuronal damage due to aluminum penetration into the nervous system may be a significant factor in autism. Read More Experimental Epilepsy in the Monkey Following Multiple Intracerebral Injections of Alumina Cream Joseph G. Chusid, Lenore M. Kopeloff, Ph.D. and Nicholas Kopeloff, Ph.D. The Bulletin, 1953. Aluminum caused tics and grand mal seizures in monkeys. Read More Macrophagic myofasciitis lesions assess long-term persistence of vaccine derived aluminum hydroxide in muscle R.K. Gherardi, M. Coquet, P. Cherin, L. Belec, P. Moretto, P.A. Dreyfus. Brain, 2001, 124, 1821-1831. French scientists tie aluminum adjuvant in vaccine to macrophagic myofasciitis. Read More Long-term persistence of vaccine-derived aluminum hydroxide is associated with chronic cognitive dysfunction Maryline Couette, Marie-Françoise Boisse, Patrick Maison, Pierre Brugieres, Pierre Cesaro, Xavier Chevalier, Romain K. Gherardi, Anne-Catherine Bachoud-Levi, François-Jérôme Authier. Journal of Inorganic Biochemistry, 2009. French scientists report aluminum from vaccines causes chronic cognitive dysfunction. Read More Aluminum in the central nervous system (CNS): toxicity in humans and animals, vaccine adjuvants, and autoimmunity Shaw C, Tomljenovic L. Immunologic Research. 2013;56:304–316. Canadian researchers: aluminum in vaccines can cause both autoimmunity and neurological damage. Read More Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: Unveiling the pathogenic, clinical and diagnostic aspects Perricone C, Colafrancesco S, Mazor RD, Soriano A, Agmon-Levin N, Shoenfeld Y. Journal of Autoimmunity. 2013;47:1-16. Israeli and Italian researchers demonstrate that exposure to aluminum in vaccines can lead to autoimmune and brain dysfunction. Read More Aluminum exposure and toxicity in neonates: a practical guide to halt aluminum overload in the prenatal and perinatal periods. Fanni D, et al. World Journal of Pediatrics, 2014 May; 10(2):101-7. Newborns have been overexposed to aluminum. Read More Neuroprotective effect of Allium cepa L. in aluminium chloride induced neurotoxicity Tanveer Singh and Rajesh Kumar Goel. NeuroToxicology, 49 (2015) 1–7. Chronic aluminium administration resulted in significant motor incoordination and memory deficits, which were also endorsed biochemically as there was increased oxidative stress as well as elevated aluminium levels in the brain. Read More Assessment of hair aluminum, lead, and mercury in a sample of autistic Egyptian children: Environmental risk factors of heavy metals in autism El Baz Mohamed F, Zaky EA, Bassuoni EI-Sayed A, et al. Behavioural Neurology. 2015, Article ID 545674. Autistic children accumulate metals at a much higher level than children who do not have a diagnosis of autism. Read More On vaccine’s adjuvants and autoimmunity: Current evidence and future perspectives Pellegrino P, Clementi E, Radice S. Autoimmunity Reviews. 2015;14(10):880-888. The specific mechanism of action of each vaccine adjuvant may have different effects on the course of autoimmune conditions resulting from vaccination Read More Aluminum in Childhood Vaccines Is Unsafe Neil Z. Miller. Journal of American Physicians and Surgeons, Winter 2016. Aluminum in vaccines is highly neurotoxic and exposure levels given to infants have dramatically increased. Read More Behavioral abnormalities in female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil Inbar R, Weiss R, Tomljenovic L, Arango M-T, Deri Y, Shaw CA, Chapman J, Blank M, Shoenfeld Y. Immunologic Research. 2017;65(1):136-149. Israeli, Canadian and Colombian scientists show that the Gardasil vaccine triggers brain inflammation and autoimmunity in mice. Read More Combined subchronic toxicity of aluminum (III), titanium (IV) and silicon (IV) oxide nanoparticles and its alleviation with a complex of bioprotectors IA Minigalieva, BA Katsnelson, LI Privalova, et al. International Journal of Molecular Sciences, March 2018;19(3):837. Aluminum nanoparticles are toxic on their own and in combination with other metal nanoparticles. Read More Synergism in aluminum and mercury neurotoxicity Peter N Alexandrov,1 Aileen I Pogue,2 and Walter J Lukiw Aluminum and mercury sulfates may contribute to neurodegeneration and progressive age-related functional decline such as Alzheimer’s disease. Read More Reconsideration of the immunotherapeutic pediatric safe dose levels of aluminum James Lyons-Weiler 1, Robert Ricketson 2 The levels of aluminum present in individual vaccines and in the modern vaccine schedule as a whole are problematically high. Read More Aluminium in brain tissue in multiple sclerosis Matthew Mold,1 Agata Chmielecka,2 Maria Raquel Ramirez Rodriguez,1 Femia Thom,2 Caroline Linhart,3 Andrew King,4 and Christopher Exley1,* The first-ever measurements of aluminum in the brain tissue of donors with multiple sclerosis detected pathologically significant levels of aluminum in every single individual. Read More Immunoexcitotoxicity as the central mechanism of etiopathology and treatment of autism spectrum disorders: a possible role of fluoride and aluminum Strunecka A, Blaylock RL, Patocka J, Strunecky O. Surgical Neurology International. 2018;9:74. Fluoride and aluminum, alone or in combination, can produce the condition of “immunoexcitotoxicity” that leads to the pathological changes seen in autism. Read More Unraveling the enigma: elucidating the relationship between the physicochemical properties of aluminium-based adjuvants and their immunological mechanisms of action Emma Shardlow, Matthew Mold & Christopher Exley Aluminum adjuvants in vaccines produce toxic effects ranging from benign to fatal, depending on the physicochemical properties of the adjuvant and the physiological response of the vaccine recipient. Read More Aluminium toxicosis: a review of toxic actions and effects Ikechukwu Onyebuchi Igbokwe, Ephraim Igwenagu, Nanacha Afifi Igbokwe. Interdiscip Toxicol. 2019; Vol. 12(2): 45–70. doi: 10.2478/intox-2019-0007 With the preliminary literature search starting in 2013 and looking backwards in time, research publications revealed a myriad of toxic actions of Aluminum causing pathological conditions. Read More Acute exposure and chronic retention of aluminum in three vaccine schedules and effects of genetic and environmental variation Journal of Trace Elements in Medicine and Biology Among the three schedules presented here, the CDC schedule exceeds the recommended dose limit for an infant (inferred from FDA adult “safe” levels) as a result of the simultaneous administration of multiple ACVs and insufficient spacing of ACVs. Read More Imaging of aluminium and amyloid β in neurodegenerative disease Christopher Exley∗ and Matthew J. Mold We suggest that complementary aluminium-specific fluorescence microscopy may reveal important information about the putative toxicity of aluminium in neurodegenerative and neurodevelopmental disorders. Read More Association Between Aluminum Exposure From Vaccines Before Age 24 Months and Persistent Asthma at Age 24 to 59 Months Academic Pediatrics In a large observational study, a positive association was found between vaccine-related aluminum exposure and persistent asthma. While recognizing the small effect sizes identified and the potential for residual confounding, additional investigation of this hypothesis appears warranted. Read More Aluminum and Alzheimer's Disease: After a Century of Controversy, Is there a Plausible Link? IOS Press The hypothesis that Al significantly contributes to AD is built upon very solid experimental evidence and should not be dismissed. Immediate steps should be taken to lessen human exposure to Al, which may be the single most aggravating and avoidable factor related to AD. Read More Aluminum adjuvant linked to gulf war illness induces motor neuron death in mice Springer The findings suggest a possible role for the aluminum adjuvant in some neurological features associated with GWI and possibly an additional role for the combination of adjuvants. Read More Administration of aluminium to neonatal mice in vaccine-relevant amounts is associated with adverse long term neurological outcomes Journal of Inorganic Biochemistry Repetitive administration of aluminium to neonatal mice in amounts comparable to those to children receive via routine vaccinations significantly increases anxiety and reduces exploratory behaviour and locomotor activities. The neurodisruptive effects of aluminium are long-lasting and persist for 6 months following injection. Read More STUDY: CDC VACCINE SCHEDULE LIKELY INDUCES ALUMINUM TOXICITY IN NEWBORNS Jefferey Jaxen A new study published in the Journal of Trace Elements in Medicine and Biology concluded the U.S. Centers for Disease Control and Prevention’s (CDC) vaccine schedule was 15.9 times over the recommended safe level of aluminum when researchers adjusted for body weight. Read More

Why I Won't Vax Home I Don't Trust Big Pharma Conflicts of Interest No Liability The Vaccine Inserts Inadequate Safety Testing Ingredients The Risks Outweigh The Benefit Unvaxxed are Healthier Decline in Illness Prior to Vaccines Vaccine Failure & Shedding Autism Vaccines Dont Cause Autism Vaccines Do Cause Autism Search Results A few years ago I started to have vaccine safety concerns. Since then, I have spent hundreds of hours searching to find The Truth About Vaccines. I have collected studies, news articles, videos, information from our regulatory agencies and big pharma and I have put it all together in one place. I hope to help others learn the truth & explain Why I Won't Vax. WHY I'M HERE Read more As someone who has worked in the healthcare industry for my entire adult life, I have always believed that vaccines were safe and effective. I received all of my vaccinations and my daughter received all of hers. When I had my son, 13 years later, I started to have questions about the necessity of giving our little ones so many vaccines at such a young age. I wondered if kids really needed to be vaccinated against chicken pox. I had the chicken pox as a child and from what I could remember it seemed to be pretty harmless. I wondered why it was so important for babies to receive a vaccination against Hepatitis B, that we give it to them on their first day of life. I knew that babies weren't at risk of Hepatitis B infection unless their mothers were Hep B positive. I wondered about the necessity of so many vaccines but I never validated these thoughts by asking questions or looking into them further. I believed that there was no way to really find honest answers around the topic of vaccinating, because any information that I would find would be biased one way or the other. So I pushed those questions to the back of my mind and I continued to follow the guidance of my government regulatory agencies and my doctors. When I was pregnant with my son I was given the Rhogam shot called Rhophylac® due to having Rh- blood type. No one ever told me that the warnings on the package insert included things like, “Rhophylac® is made from human plasma. Products made from human plasma may contain infectious agents, e.g., viruses and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent, that can cause disease” or, “such products can still potentially transmit disease. There is also the possibility that unknown infectious agents may be present in such products” or, “as reported in the literature, some patients treated with Rh0(D) immune globulin (anti-D) developed clinically compromising anemia, acute renal insufficiency, and, very rarely, disseminated intravascular coagulation (DIC) and death“. At the same time I was also given a vaccine for Tetanus, Diphtheria, and Pertussis called Boostrix. This vaccine is only authorized for use in people age 10+. To determine the safety in pregnant women there was one study done using the non US formulation of Boostrix. In this study they gave half of the pregnant women Boostrix and half got a saline placebo. AN ACTUAL SALINE PLACEBO! Except once the babies in the placebo group were born they were also given Boostrix (again Boostrix is only authorized for children ages 10 and up). Researchers then compared the outcomes of babies who's mothers received Boostrix while pregnant with the babies who received Boostrix after delivery. Since the outcomes were similar in both groups it was determined Boostrix was safe to give during pregnancy and is now given to every pregnant woman routinely. I did not know this at the time and I did not know to ask. I did not know to read the vaccine insert before allowing myself and my unborn child to be exposed to vaccines. If I would have known I would have saw that right in the 38 page vaccine insert it states side effects such as, “Convulsions (with and without fever), encephalitis, facial palsy, loss of consciousness, paresthesia”. I would have seen that none of the safety studies were ever truly testing Boostrix against an actual placebo. Or that the longest follow up period looking for adverse events was 6 months. If I would have known I might have made a different choice. In fact, if I would have known I absolutely WOULD have made a different choice. My son was born August 8, 2018. Within hours of being born he was vaccinated with the Hepatitis B vaccine. The package insert states that, “In 36 clinical studies, a total of 13,495 doses of ENGERIX-B were administered to 5,071 healthy adults and children who were initially seronegative for hepatitis B markers, and healthy neonates. All subjects were monitored for 4 days post-administration.” They monitored subjects for 4 days. Take a moment to think about that. 4 DAYS. Also, how many of these subjects were born just a few hours before receiving the vaccine? The post marketing surveillance lists side effects such as, “Herpes zoster, meningitis, Encephalitis; encephalopathy; migraine; multiple sclerosis; neuritis; neuropathy including hypoesthesia, paresthesia, Guillain-Barré syndrome and Bell’s palsy; optic neuritis; paralysis; paresis; seizures; syncope; transverse myelitis.“ In a quick review of the FDA licensing documents I was unable to find any real information regarding the safety studies done prior to approval of this vaccine for use in babies on their first day of life. However, I was able to find a study while searching PubMed* that shows boys who are vaccinated with Hepatitis B vaccine within the first month of life have a three fold higher risk of autism than boys who are not vaccinated until after one month. Why in the world would we not wait? Two months later, I received a flu shot. I normally never got the flu shot but this year I did. I was told it was the best way to protect my new baby, by forming a cocoon around him so-to-speak. Once again, had I read the package insert I would have seen that it stated, “It is not known whether Fluzone Quadrivalent is excreted in human milk. Data are not available to assess the effects of Fluzone Quadrivalent on the breastfed infant or on milk production/excretion.The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for Fluzone Quadrivalent and any potential adverse effects on the breastfed child from Fluzone Quadrivalent or from the underlying maternal condition. For preventive vaccines, the underlying maternal condition is susceptibility to the disease prevented by the vaccine”. I was never told about any risks or lack of safety studies done on receiving this vaccine while breastfeeding. I was only encouraged to take it. A week later my son received 5 more vaccines. He was seen in urgent care 4 times following that visit and finally diagnosed as failure to thrive by the Emergency Room doctor at Children’s Hospital. A week later, 5 more vaccinations. He stopped eating, stopped sleeping, stopped gaining weight, and screamed non-stop. After that we decided to do a delayed vaccination schedule. Only doing one vaccine at each well-child visit. Our doctor was not supportive of this and we were forced to find a new doctor. After every vaccine he would scream inconsolably for a week. But I continued to get him vaccinated as if there wasn’t another choice. He started to show developmental delays. Despite scoring 109 during a developmental assessment at two months old, well above the cutoff score of 78, he was no longer meeting milestones. A year later he received the same developmental assessment and this time he scored 62. My concerns about my son were validated when he was 19 months old. He was diagnosed with Autism Spectrum Disorder, Global Developmental Delay, and Speech Disorder. I don’t believe that my sons life had to go this way. I believe that we were never informed about the real dangers associated with vaccinating and that if we had not vaccinated he would be healthier today. Vaccinating him is a decision I wish very much that I could take back. I believe that due to my lack of knowledge around vaccines I failed to protect my son and that he faces many struggles today that were unnecessary. I would never tell another parent what decisions to make when it comes to their kids medical care. But I do want parents to have the information before making those decisions. The information is not always biased like I thought. Most of the information I have found comes directly from the manufacturers of the products themselves, or from our regulatory agencies like the CDC and the FDA. The truth is out there you just have to know how to find it. So I decided to put all of the information I have collected into one place that’s easy for people to find and share. That is what this website is. If it helps just one parent feel more informed and empowered to speak up and ask questions about what is being given to their children then it's served it's purpose. Main Issues I Don't Trust Big Pharma Conflicts of Interest The Inserts Inadequate Safety Testing Ingredients Risk Out-Weighs Benefits Decline in Illness Prior to Vaccines Autism No Liability for Injury Covid-19 Vaccines Vaccine Failure & Shedding Other Effective Treatment Opti ons Resources Blog Posts May 7 2 min More Stuff I've spent countless hours working on this website. Every spare minute I had for months, because once I got started I was anxious to get... 1 0 Feb 16 5 min I Wish I Would Have Known Most "anti-vaxxers" weren't always antivax. We are vaxed & we vaxed our kids. It wasnt until our kids were injured that we learned the truth 16 0 Feb 9 4 min Other Resources Resources for learning the truth about vaccine safety 4 0 Jan 30 1 min 89 Studies on Mercury Peer reviewed published articles linking autism, mercury and thimerosal 5 0 Nov 2, 2022 5 min CDCs ACIP committee voted 15:0 to add the Covid-19 vaccine to the childhood immunization schedule CDCs ACIP committee voted 15:0 to add the Covid-19 vaccine to the childhood immunization schedule starting early 2023. 10 0 Oct 22, 2022 6 min 14 ACIP Members Who Voted to Jab Your Young Children — and Their Big Ties to Big Pharma Here is a summary of an article by CHD outlining the conflicts of interest in the ACIP members who approved covid vaccines for kids 3 0 VIEW ALL BLOG POSTS Do you have questions or comments? I would love to hear your thoughts! G info@WhyIWontVax.com First Name Last Name Email Message Send Thanks for submitting! BACK TO TOP

Why I Won't Vax Home I Don't Trust Big Pharma Conflicts of Interest No Liability The Vaccine Inserts Inadequate Safety Testing Ingredients The Risks Outweigh The Benefit Unvaxxed are Healthier Decline in Illness Prior to Vaccines Vaccine Failure & Shedding Autism Vaccines Dont Cause Autism Vaccines Do Cause Autism Search Results We have all been told at some point that it's important for everyone to get vaccinated in order to protect those who can't. We are given the image of a sick, immunocompromised child and told that this child will not be able to attend school with their peers, or go out into the community unless we all get vaccinated. Only then will we reach "heard immunity", protecting the child from illness by forming a sort of cocoon of protection around them. This idea sounds great in theory. I even fell for it after having my son. I dutifully went out and got my flu shot to protect my precious new baby boy. However, there are several holes in the theory. Vaccine Failure Shedding/ Vaccine Derived Disease Waning Immunity influenza vaccine propaganda by Jeremy R. Hammond Part One: Myths and Facts about Flu Shots Part Two: How the CDC Uses Fear and Deception to Sell More Flu Vaccines Part Three: How You’re Being Lied to about the Risks of Getting a Flu Vaccine Annually Vaccine Failure View More Featured The topic of vaccine failure has become increasingly popular over the last few years. We were told that vaccines would be the only way out of the pandemic. We were told that it was a "pandemic of the unvaccinated". We were told if we got vaccinated we would not get sick and that we would be protecting others from getting sick. I think it is safe to say that none of those things are true. It has a lot of people talking about what a failure these vaccines are. People rightfully feel as though they were lied to. But vaccine failure didn't start with the coivd vaccines. An article from Medical University Vienna describes vaccine failure "There are 2 major factors responsible for vaccine failures, the first is vaccine-related such as failures in vaccine attenuation, vaccination regimes or administration. The other is host-related, of which host genetics, immune status, age, health or nutritional status can be associated with primary or secondary vaccine failures. The first describes the inability to respond to primary vaccination, the latter is characterized by a loss of protection after initial effectiveness. " The article states that, "about 2-10% of healthy individuals fail to mount antibody levels to routine vaccines." Although it varies, some diseases such as measles need 95% vaccination rates in order to reach heard immunity. That means if every person that could get vaccinated did we likely still would not reach herd immunity. Immunized People Getting Whooping Cough June 12, 2014 By Joanne Faryon / Investigative Reporter, KPBS Staff Of the 621 people who contracted the illness, 85 percent had all their preventative shots — calling into question the efficacy of the vaccine. Read More The Re-Emergence of Measles in Developed Countries: Time to Develop the Next-Generation Measles Vaccines? January 5, 2012 Gregory A. Poland, MD, MACP, Editor-in-Chief, VACCINE and Robert M. Jacobson, MD, FAAP, Professor of Pediatrics Multiple studies demonstrate that 2–10% of those immunized with two doses of measles vaccine fail to develop protective antibody levels, and that immunity can wane over time and result in infection (so-called secondary vaccine failure) when the individual is exposed to measles. In an October 2011 outbreak in Canada, over 50% of the 98 individuals had received two doses of measles vaccine. Read More United States ex rel. Krahling v. Merck & Co. August 27, 2010 Nstural News Relators Krahlillg and WlochoWBki were OOlpioyed as virologists in the Merck lub that perlOOne3000 in DTwP vaccines), linked-epitope suppression occurs. Because of linked-epitope suppression, all children who were primed by DTaP vaccines will be more susceptible to pertussis throughout their lifetimes, and there is no easy way to decrease this increased lifetime susceptibility. Read More Vaccinated child had Maine’s first case of measles in 2 years, say health officials May 21, 2019 BY JOE LAWLOR STAFF WRITER “The child is vaccinated, did not have any serious complications, and is fully recovered from the disease,” Read More The Pink Book ​ Centers for Disease Control -From 1985 through 1988, 68% of cases in school-aged children (age 5 to 19 years) occurred among those who had been appropriately vaccinated -In 2019, 13 outbreaks of measles were reported, accounting for 663 cases; six were associated with underimmunized close-knit communities -The original Edmonston B vaccine was withdrawn in 1975 because of a relatively high frequency of fever and rash in recipients. -Approximately 2% to 7% of children who receive only 1 dose of MMR vaccine fail to respond to it, i.e., they experience primary vaccine failure. MMR vaccine failure can occur because of passive antibody in the vaccine recipient, immaturity of the immune system, damaged vaccine, or other reasons. -Most adverse events reported following MMR vaccination (such as fever and rash) are attributable to the measles component. - “During the 1989 -1991 measles resurgence, incidence rates for infants were more than twice as high as those in any other age group. The mothers of many infants who developed measles were young, and their measles immunity was most often due to vaccination rather than infection with wild virus. As a result, a smaller amount of antibody was transferred across the placenta to the fetus, compared with antibody transfer from mothers who had higher antibody titers resulting from wild-virus infection. The lower quantity of antibody [in the vaccine] resulted in immunity that waned more rapidly, making infants susceptible at a younger age than in the past.” Read More The relationship between mucosal immunity, nasopharyngeal carriage, asymptomatic transmission and the resurgence of Bordetella pertussis [version 1; peer review: 2 approved] August 25, 2017 Christopher J. Gill Pejman Rohani, Donald M Thea In conclusion, the preponderance of available evidence now suggests that the list of plausible explanations for the resurgence of pertussis in the aP vaccination era goes beyond the “poor persistence” and “waning efficacy” of these vaccines to include an additional and likely pivotal factor: “lack of sterilizing mucosal immunity”. the current burden of disease is not well explained by the disease that is observed but implies asymptomatic chains of transmission; aP vaccination, or passively acquired antibodies resulting from aP vaccination, prevents symptomatic disease in animals but does not block infections; transmission readily occurs between asymptomatic aP-vaccinated but infected animals to uninfected animals in close physical proximity; Read More Fifty-one percent of cases of patients in a 1998/1999 mumps outbreak had at least one MMR vaccination, indicating their effectiveness may be overestimated. July 1, 2005 Richard Harling, Joanne M White, Mary E Ramsay, Karen F Macsween, Corry van den Bosch The observed effectiveness of any MMR vaccination adjusted for age, sex and general practice was 69%. - Two doses of vaccine were more effective (88%) than a single dose (64%). Read More The Navy's fighting to get a rare viral mumps outbreak under control after it stranded a US warship at sea March 29, 2019 Business INSIDER Ryan Pickrell -27 sailors and Marines aboard the dock landing ship USS Fort McHenry have been diagnosed with parotitis, which the Navy described in a statement earlier this month as a "viral infection which has symptoms similar to mumps." -Viral parotitis is an infection of the saliva glands on either side of the face that's typically caused by the mumps. -“The Navy’s position is that vaccines are effective at reducing the incidence and severity of vaccine-preventable diseases,” BUMED told BI. Unfortunately, “the mumps portion of the measles, mumps, and rubella (MMR) vaccine is the least effective of the three components, providing 88% effectiveness after completion of the two dose series” Read More Load More Shedding/Vaccine Derived Disease From MerckVaccines.com Re: Varivax (Chickenpox) Vaccine Due to the concern for transmission of vaccine virus, vaccine recipients should attempt to avoid, whenever possible, close association with susceptible high-risk individuals for up to 6 weeks following vaccination . .Vaccine recipients should avoid close contact with high-risk individuals susceptible to varicella due to possible risk of transmission . Varicella vaccine virus transmission may occur between vaccine recipients and contacts susceptible to varicella including healthy individuals. Other reported adverse reactions in all age groups include: varicella-like rash (injection site) and varicella-like rash (generalized). VARIVAX may establish latency of varicella zoster virus in immunocompetent individuals, with the potential for later development of herpes zoster. From Merck.com M-M-R® II (Measles, Mumps, and Rubella Virus Vaccine Live) Measles inclusion body encephalitis (MIBE), pneumonitis, and death as a direct consequence of disseminated measles vaccine virus infection have been reported in immunocompromised individuals inadvertently vaccinated with measles-containing vaccine. In this population, disseminated mumps and rubella vaccine virus infection have also been reported. The following adverse reactions include those identified during clinical trials or reported during post-approval use of M-M-R II vaccine or its individual components. atypical measles​ measles inclusion body encephalitis (MIBE) measles-like rash RotaTeq- Rotavirus Vaccine "The spread of vaccine virus to non-vaccinated contacts has been reporte d. Tell your doctor if you have someone in your household who has a weak immune system, cancer, or is taking medications that can weaken the immune system so that your doctor can provide further advice." FluMist® Quadrivalent (Influenza Vaccine Live, Intranasal) Intranasal Spray From The Insert Shedding Studies Shedding of vaccine viruses within 28 days of vaccination with FluMist was evaluated in (1) multi-center Study MI-CP129 which enrolled healthy individuals 6 through 59 months of age (N = 200); and (2) multi-center Study FM026 which enrolled healthy individuals 5 through 49 years of age (N = 344). In each study, nasal secretions were obtained daily for the first 7 days and every other day through either Day 25 and on Day 28 or through Day 28. In Study MI-CP129, individuals with a positive shedding sample at Day 25 or Day 28 were to have additional shedding samples collected every 7 days until culture negative on 2 consecutive samples. Results of these studies are presented in Table 5 Measles outbreak in a fully immunized secondary-school population T L Gustafson, A W Lievens, P A Brunell, R G Moellenberg, C M Buttery, L M Sehulster Serum samples from 1806 students at two secondary schools were obtained eight days after the onset of the first case. Only 4.1 percent of these students (74 of 1806) lacked detectable antibody to measles according to enzyme-linked immunosorbent assay, and more than 99 percent had records of vaccination with live measles vaccine. We conclude that outbreaks of measles can occur in secondary schools, even when more than 99 percent of the students have been vaccinated and more than 95 percent are immune. March 26, 1987 Read More Spotlight on measles 2010: Excretion of vaccine strain measles virus in urine and pharyngeal secretions of a child with vaccine associated febrile rash illness, Croatia, March 2010 separator commenting unavailable B Kaic1 , I Gjenero-Margan1 , B Aleraj1 , T Vilibić-Čavlek2 , M Santak3 , A Cvitković4 , T Nemeth-Blazic1 , I Ivic Hofman4 We describe excretion of measles vaccine strain Schwarz in a child who developed a febrile rash illness eight days after primary immunisation against measles, mumps and rubella. Throat swabs and urine specimens were collected on the fifth and sixth day of illness, respectively. Genotyping demonstrated measles vaccine strain Schwarz (genotype A). If measles and rubella were not under enhanced surveillance in Croatia, the case would have been either misreported as rubella or not recognised at all June 4, 2010 Read More Shedding of Infectious SARS-CoV-2 Despite Vaccination Kasen K. Riemersma, DVM, PhD1 ; Brittany E. Grogan, MPH2 ; Amanda Kita-Yarbro, MPH2 ; Peter J. Halfmann, PhD1 ; Hannah E. Segaloff, PhD3 ; Anna Kocharian, MS4 ; Kelsey R. Florek, MPH, PhD5 ; Ryan Westergaard, MD, PhD6 ; Allen Bateman, PhD5 ; Gunnar E. Jeppson, BS7 ; Yoshihiro Kawaoka, DVM, PhD1 ; David H. O’Connor, PhD8 ^; Thomas C. Friedrich, PhD1 ^; Katarina M. Grande, MPH2 ^ these results indicate that even asymptomatic, fully vaccinated people might shed infectious virus. August 21, 2021 Read More Oral polio vaccinees can continue to shed for at least 13 weeks. Stephanie B Troy, Leticia Ferreyra-Reyes, Chunhong Huang, Nadim Mahmud, Yu-Jin Lee, Sergio Canizales-Quintero, Harry Flaster, Renata Báez-Saldaña, Lourdes García-García, Yvonne Maldonado During replication, oral polio vaccine (OPV) can revert to neurovirulence and cause paralytic poliomyelitis. In individual vaccinees, it can acquire specific revertant point mutations, leading to vaccine-associated paralytic poliomyelitis (VAPP). With longer replication, OPV can mutate into vaccine-derived poliovirus (VDPV), which causes poliomyelitis outbreaks similar to those caused by wild poliovirus. Our real-time PCR assay was able to detect small amounts of OPV in both stool and sewage and to distinguish nonrevertant and revertant serotypes and demonstrated that OPV continues to circulate at least 13 weeks after a NID in a Mexican population routinely immunized with IPV. March 16, 2011 Read More Differentiating the wild from the attenuated during a measles outbreak Lindsay Nestibo, BN RN, Bonita E Lee, MD FRCPC MSC (Epi), Kevin Fonseca, PhD D(ABMM), Jennifer Beirnes, Marcia M Johnson, MD MHSc FRCPC, Christopher A Sikora, MD MSc MPH CCFP FRCPC In the midst of a local measles outbreak, a recently immunized child was investigated for a new-onset measles-type rash. Nucleic acid testing identified that a vaccine-type measles virus was being shed in the urine. April 1, 2012 Read More Case of vaccine-associated measles five weeks post-immunisation, British Columbia, Canada, October 2013 M Murti1 , M Krajden2 , M Petric2 , J Hiebert3 , F Hemming1 , B Hefford4 , M Bigham1 , P Van Buynder1 We describe a case of vaccine-associated measles in a two-year-old patient from British Columbia, Canada, in October 2013, who received her first dose of measles-containing vaccine 37 days prior to onset of prodromal symptoms. Identification of this delayed vaccine-associated case occurred in the context of an outbreak investigation of a measles cluster. November 15, 2013 Read More Circulating vaccine-derived poliovirus type 2 – Global update The World Health Organization In 2020, 959 human cases of circulating vaccine-derived poliovirus type 2 (cVDPV2) and 411 cVDPV2-positive environmental samples were reported globally from 27 countries March 26, 2021 Read More Of the 13,749 acute flaccid paralysis cases investigated, 58.9% received at least three doses of oral polio vaccine. Hugo Kavunga Membo, Aaron Mweene, Serge Alain Sadeuh-Mba, Justin Masumu, Riziki Yogolelo, Norbert Ngendabanyikwa, Eddy Sokolua, Fred Sagamiko, Edgar Simulundu, Steve Ahuka, Jean Jacques Muyembe Of the 13,749 AFP cases investigated, 58.9% received at least three doses of oral polio vaccine (OPV), 7.3% never received OPV, while the status of 18.3% was unknown. June 22, 2016 Read More Detection of measles vaccine in the throat of a vaccinated child Florence Morfin a, Anne Beguin b 1, Bruno Lina a, Danielle Thouvenot a We report here the case of a child presenting with fever 8 days after vaccination with a measles–mumps–rubella vaccine. Measles virus was isolated in a throat swab taken 4 days after fever onset. This virus was then further genetically characterised as a vaccine-type virus. February 22, 2002 Read More Post-vaccine measles in a child with concomitant influenza, Sicily, Italy, March 2015 F Tramuto1,2 , P Dones3 , C D’Angelo4 , N Casuccio4 , F Vitale1,2 We describe the occurrence of measles in an 18 month-old patient in Sicily, Italy, in March 2015, who received the first dose of a measles-containing vaccine seven days before onset of prodromal symptoms. Measles virus infection was confirmed by PCR and detection of specific immunoglobulin; viral genotyping permitted the confirmation of a vaccine-associated illness. May 7, 2015 Read More In 2011, there were an extra 47,500 new cases of non-polio acute flaccid paralysis (NPAFP); Clinically indistinguishable from polio paralysis but twice as deadly, the incidence of NPAFP was directly proportional to doses of oral polio received. Neetu Vashisht, Jacob Puliyel In 2011, there were an extra 47,500 new cases of NPAFP. Clinically indistinguishable from polio paralysis but twice as deadly, the incidence of NPAFP was directly proportional to doses of oral polio received. Though this data was collected within the polio surveillance system, it was not investigate April 1, 2012 Read More At the present time, the only poliovirus-caused poliomyelitis cases reported in Brazil and other countries of the Americas are of vaccine etiology. L H de Oliveira, C J Struchiner At the present time, the only poliovirus-caused poliomyelitis cases reported in Brazil and other countries of the Americas are of vaccine etiology. Among individuals who had received oral polio vaccine (OPV) from 4 to 40 days before the onset of paralysis, we found a relative risk of 8.88 (95% CI: 4.37-18.03) for VAPP as compared with persons who had not been vaccinated during the same time interval. A major share of VAPP cases were related to children affected by prodromes (fever and gastrointestinal signs and/or symptoms), isolation of vaccine poliovirus type 2, paralysis of the lower limbs, and a mean age of 1 year. April 1, 2000 Read More Load More Waning Immunity "There are insufficient data to assess the rate of protection of VARIVAX against the serious complications of chickenpox in adults (eg, encephalitis, hepatitis, pneumonia), and during pregnancy (congenital varicella syndrome)." ​ "The duration of protection from varicella infection after vaccination with VARIVAX is unknown." merckvaccines.com/varivax/ Annual Vaccination against Influenza Virus Hampers Development of Virus-Specific CD8+ T Cell Immunity in Children " long-term annual vaccination using inactivated vaccines may hamper the induction of cross-reactive CD8+ T cell responses by natural infections and thus may affect the induction of heterosubtypic immunity. This may render young childr en who have not previously been infected with an influenza virus more susceptible to infection with a pandemic influenza virus of a novel subtype ." Journal of Virology Whooping Cough Outbreak: How Effective Is the Vaccine? ​ Widespread pertussis vaccine use at a Florida preschool failed to keep the disease away from about three dozen students, staff and family members By Cari Nierenberg , LiveScience on January 14, 2016 SCIENTIFIC AMERICAN Waning Tdap Effectiveness in Adolescents Klein NP, Bartlett J, Fireman B, Baxter R. Waning Tdap Effectiveness in Adolescents. Pediatrics. 2016 Mar;137(3):e20153326. doi: 10.1542/peds.2015-3326. Epub 2016 Feb 5. PMID: 26908667. Routine Tdap did not prevent pertussis outbreaks. Among adolescents who have only received DTaP vaccines in childhood, Tdap provided moderate protection against pertussis during the first year and then waned rapidly so that litle protection remained 2-3 years after vaccination.. ​ https://pubmed.ncbi.nlm.nih.gov/26908667/ Home Page BACK TO TOP Autism

Why I Won't Vax Home I Don't Trust Big Pharma Conflicts of Interest No Liability The Vaccine Inserts Inadequate Safety Testing Ingredients The Risks Outweigh The Benefit Unvaxxed are Healthier Decline in Illness Prior to Vaccines Vaccine Failure & Shedding Autism Vaccines Dont Cause Autism Vaccines Do Cause Autism Search Results Covid Sign in Covid Play Video Share Whole Channel This Video Facebook Twitter Pinterest Tumblr Copy Link Link Copied Search video... All Categories All Categories Now Playing covid death rates austrailia and niger 00:42 Play Video Now Playing Maddie de Garay Injured in vaccine trials 00:30 Play Video Now Playing ‘Colossal_Failure’_Did_This_Just_Become_the_Worst_Public_Health 01:53 Play Video Now Playing Jessica Rose discussing vaccine ingredients 02:13 Play Video BACK TO TOP

Why I Won't Vax Home I Don't Trust Big Pharma Conflicts of Interest No Liability The Vaccine Inserts Inadequate Safety Testing Ingredients The Risks Outweigh The Benefit Unvaxxed are Healthier Decline in Illness Prior to Vaccines Vaccine Failure & Shedding Autism Vaccines Dont Cause Autism Vaccines Do Cause Autism Search Results Risk-Benefit Ratio Nothing in this world comes without some sort of risk. One example is sunlight. It is hugely beneficial for us. It has been shown to lower blood pressure, improve mood and sleep, and it is also enables the body to make Vitamin D. However, too much sunlight along with possible other risk factors can lead to skin cancer. ​ Every thing, regardless of the potential for good, also has the potential for bad. We decide each day which risks we are willing to take in order to receive the benefits that come with it. But when it comes to vaccines, we are only told that they are "Safe and Effective". Even if that is true, there still has to be SOME risks associated with using them. They can't possibly be the ONLY thing in the world without risks. ​ So what are the risks? How severe are they? How common are they? Are some people more prone to risks than others? ​ Do the benefits outweigh the risks???? From The Children's Health Defense Vaccine Injuries Ratio: One for Every 39 Vaccines Administered This article from The Children's Health Defense looks at a 2010 U.S. Health and Human Services (HHS) pilot study by the Federal Agency for Health Care Research (AHCR) to test the efficiency of a state-of-the-art machine counting (AI) system on data records from the Harvard Pilgrim HMO and finds vaccine injury occur at a rate of 1 in 39. Read the article here Evidence of Increase in Mortality After the Introduction of Diphtheria-Tetanus-Pertussis Vaccine to Children Aged 6-35 Months in Guinea-Bissau: A Time for Reflection? "Although having better nutritional status and being protected against three infections, 6-35 months old DTP-vaccinated children tended to have higher mortality than DTP-unvaccinated children. All studies of the introduction of DTP have found increased overall mortality" Read More What is VAERS? Read more The Vaccine Adverse Event Reporting System, or VAERS, is a post-licensure vaccine safety monitoring system used in the United States. VAERS is a passive monitoring system, meaning it relies on on individuals to report adverse events following vaccination. Anyone can make a report to VAERS which can lead to over- or under-reporting. VAERS cannot assess causality between adverse events and receipt of a vaccine and it cannot calculate the incidence or prevalence of an event or determine an increased risk for an event. VAERS can be useful for detecting unusual or unexpected patterns of adverse event reporting that might indicate a possible safety problem with a vaccine. It is the only national surveillance system in place to monitor post marketing safety of vaccines. HOW RELIABLE IS VAERS DATA? In a project funded by HHS, Harvard Pilgrim Health Care collected data from 715,000 patients over a 3 year period. The goal of the project was to "improve the quality of vaccination programs by improving the quality of physician adverse vaccine event detection and reporting to the national Vaccine Adverse Event Reporting System (VAERS)". They developed a system that would automate reporting of adverse events based through electronic monitoring of medical records. During this project they also evaluated the performance of the VAERS system. They state in the report that "Adverse events from drugs and vaccines are common, but underreported. Although 25% of ambulatory patients experience an adverse drug event, less than 0.3% of all adverse drug events and 1-13% of serious events are reported to the Food and Drug Administration (FDA). Likewise, fewer than 1% of vaccine adverse events are reported". ​ Although they were able to develop a way to automate reporting the CDC did not move forward with the program. From the report, "Unfortunately, there was never an opportunity to perform system performance assessments because the necessary CDC contacts were no longer available and the CDC consultants responsible for receiving data were no longer responsive to our multiple requests to proceed with testing and evaluation. " Electronic Support for Public Health–Vaccine Adverse Event Reporting System (ESP:VAERS) Evidence of Serious Adverse Events in What Is Believed to Be One of the Most Effective Vaccines (Part 1) ​ The Truth About HPV Vaccines: Part I Link to full article Concerns of Increased Neurological and Autoimmune Events After HPV Vaccines: Large Studies (Part 2) The Truth About HPV Vaccines: Part II Link to full article Vaxxed vs Un-Vaxxed Who has better health outcomes overall? See The Vaxxed vs Un-Vaxxed Studies Kids Are Sicker Than Ever Chronic illness in kids has hit an all time high. See The Numbers Adverse Events & Risks Associated With Vaccination Spontaneous Abortion Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women View Study Eczema Vaccinatum Eczema vaccinatum resulting from the transmission of vaccinia virus from a smallpox vaccinee: an investigation of potential fomites in the home environment View Study Fibromyalgia Fibromyalgia, infection and vaccination: two more parts in the etiological puzzle View Study Bells Palsy Safety of Quadrivalent Meningococcal Conjugate Vaccine in 11- to 21-Year-Olds View Study Eczema Vaccinatum Severe eczema vaccinatum in a household contact of a smallpox vaccinee View Study Hearing Loss Reports of sensorineural deafness after measles, mumps, and rubella immunisation View Study Cardiorespiratory Events Adverse events following vaccination in premature infants View Study Bell's palsy, Paraesthesia, and Inflammatory Bowel Disease Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden View Study Vaccinia How Contagious Is Vaccinia? View Study Hearing Loss Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003 View Study Myopericarditis Acute myopericarditis after multiple vaccinations in an adolescent: case report and review of the literature View Study Autism Do aluminum vaccine adjuvants contribute to the rising prevalence of autism? View Study Load More BACK TO TOP Home Page Unvaxxed Are Healthier

Why I Won't Vax Home I Don't Trust Big Pharma Conflicts of Interest No Liability The Vaccine Inserts Inadequate Safety Testing Ingredients The Risks Outweigh The Benefit Unvaxxed are Healthier Decline in Illness Prior to Vaccines Vaccine Failure & Shedding Autism Vaccines Dont Cause Autism Vaccines Do Cause Autism Search Results "clinical trials are almost always too small to provide useful information on serious rare events"" -the Committee on Government Reform How are Pharmaceutical Products Tested Stanley Plotkin on Hepatitis B Vaccines FDA approves Tdap in pregnancy Video from The Highwire The Truth About HPV Vaccination The Institute of Medicine Report Phase 3 Control groups Toxicology Inadequate Safety Testing Most people have probably never given much thought as to how vaccines are tested before being licensed. We are told they are "Safe and Effective", and so we assume they must have gone through strict testing by our regulatory agencies to assure that they in fact are. However, our regulatory agencies don't do any pre-licensing tests to determine the safety and efficacy of vaccines. They rely on the vaccine manufacturers to do their own safety studies. "The U.S. Food and Drug Administration (FDA) ensures the safety, effectiveness, and availability of vaccines for the United States. Before the FDA licenses (approves) a vaccine, the vaccine is tested extensively by its manufacturer. FDA scientists and medical professionals carefully evaluate all the available information about the vaccine to determine its safety and effectiveness." How Are Pharmaceutical Products Tested? ​ A placebo is defined as an innocuous or inert medication, such as saline. Using a placebo is also important as helps to determine what types of adverse events may be related to the substance being tested. It helps to distinguish between correlation or causation. If there is a statistically significant difference in the number of adverse events in the group receiving the subst ance being tested, compared to the number of adverse events in the group receiving a placebo, then there is a likelihood that the adverse events were caused by the substance being tested. The same idea would be used to check for efficacy. ​ This type of study seems like it would be the common sense way to test a new pharmaceutical product. Surprisingly, none of the vaccines currently on the childhood immunization schedule, with the exception of the newly added Covid-19 vaccine, have ever been tested in a randomized double blind placebo study. ​ On this page I will show each vaccine that is currently licensed and on our CDC childhood vaccine schedule, highlighti ng what was used in the control groups for each of the pre-licensing studies . I will also add articles and information regarding the lack of safety testing done on vaccines. The "Gold Standard" when it comes to testing new pharmaceuticals is a Randomized Double Blind Placebo Study. Participants are randomly selected to receive the substance being tested or a placebo. Double blind means that neither the participants, nor the researchers know which participants are receiving which substance. This study design helps protect the results from bias. From The Highwire HEPATITIS B VACCINE SAFETY TESTED FOR JUST FIVE DAYS ​ Dr. Stanley Plotkin, widely considered the world’s leading authority on vaccines, is questioned by ICAN Lead Attorney Aaron Siri, Esq. about the pre-licensure safety testing of the Hepatitis B vaccine, a vaccine given to babies in their first days of life in the U.S. FDA Documents reveal the vaccine was followed for safety for just five days in the trials. Watch More FDA Approves Vaccine for Use During Third Trimester of Pregnancy to Prevent Whooping Cough in Infants Younger Than Two Months of Age "The safety of Boostrix administered during the third trimester of pregnancy was assessed in a randomized, placebo-controlled study with a non-U.S. formulation of Boostrix. The study included approximately 680 pregnant individuals of whom about 340 received the non-U.S. formulation of Boostrix and of whom about 340 received saline placebo. After childbirth, the placebo recipients were then vaccinated with the non-U.S. formulation of Boostrix. The rates of reported side effects following receipt of the non-U.S. formulation of Boostrix administered during pregnancy were consistent with the rates following receipt of the non-U.S. formulation of Boostrix administered to study participants after childbirth." Read More From The Highwire ICAN DEMANDS FDA WITHDRAW HEP B VACCINE ​ The Informed Consent Action Network (icandecide.org) has filed a petition, under penalty of perjury, demanding the FDA withdraw licensure for Hepatitis B vaccines due to non-compliance with applicable federal and statutory regulatory requirements. Both Hepatitis B vaccines licensed in the United States were tested for safety for a maximum of 5 days post injection. View More From The Children's Health Defense The Truth About HPV Vaccination, Part 3: Can It Prevent Cervical Cancer? There are no valid studies showing the vaccine for the human papillomavirus, or HPV, prevents cervical cancer. However, there are studies suggesting the vaccine could increase the risk of cancer. Most of the HPV’s interventional clinical trials have too short a follow-up time to draw a concrete conclusion. Lack of long-term follow-up is a common issue for most clinical trials to prove the HPV vaccine’s effectiveness in preventing cervical cancer. For example, a 2007 study found that Gardasil was effective in reducing HPV-associated cervical precancerous lesions rate by 20%. This study followed their subjects for only an average of three years after administration of the first dose. Meanwhile, the median time from CIN2/3 to transition to cancer is estimated to be 23.5 years. Read More From The Institute of Medicine Report Adverse Effects of Pertussis and Rubella Vaccines “In the course of its review, the committee encountered many gaps and limitations in knowledge bearing directly and indirectly on the safety of vaccines. These include inadequate understanding of the biologic mechanisms underlying adverse events following natural infection or immunization, insufficient or inconsistent information from case reports and case series, inadequate size or length of follow-up of many population-based epidemiologic studies, and limited capacity of existing surveillance systems of vaccine injury to provide persuasive evidence of causation. The committee found few experimental studies published in relation to the number of epidemiologic studies published. Clearly, if research capacity and accomplishment in these areas are not improved, future reviews of vaccine safety will be similarly handicapped.” SEE THE FULL REPORT HERE VARIVAX Package insert states that Varivax was tested for safety in a double blind placebo controlled study however the placebo given to the control group was actually the vaccine minus the viral component. immunogenicity followed for 10 years but safety endpoints were monitored for 6 weeks TDVAX Insert states "Data on adverse reactions following fluid and adsorbed preparations of MassBiologics’ TDVAX with various doses of the diphtheria and tetanus components have been reported in a series of studies." It gives no other details regarding clinical trials. . TENIVAC Participants age 11-59 all received TENIVAC. Participants age 60 and older received TENIVAC or DECAVAC and the study was unblinded to pharmacists and vaccination nurses 3 days-30 days Boostrix BOOSTRIX or Td vaccine or comparator Tdap vaccine. The safety of vaccinating during pregnancy was evaluated in a study where The placebo recipients received the non-U.S. formulation of BOOSTRIX postpartum. "The rates of reported solicited adverse reactions following receipt of the non-U.S. formulation of BOOSTRIX administered during pregnancy were consistent with the rates following receipt of the non-U.S. formulation of BOOSTRIX administered to study participants postpartum." subjects were monitored for solicited adverse events using standardized diary cards during the 4 days (Days 0 to 3), 8 days (Days 0 to 7), or 15 days (Days 0 to 14) following vaccination. Unsolicited adverse events were monitored for the 31-day period following vaccination (Days 0 to 30) Adacel Adacel or Td vaccine Up to 6 months RotaTeq The insert states subjects in the clinical trials received placebo. The description of the placebo was removed from licensing documents. Documents show that one clinical trial the placebo used was the Vaccine minus the antigen. Licensing documents also show that all participants also received several other vaccines concomitantly. 42 days up to 1 year ROTARIX Insert mentions a placebo but licensing documents show that the placebo was actually the vaccine being tested minus the antigen component. 8 -31 days IPOL Tested in 1980-1983 control group received the oral polio vaccine. All participants also received DTP vaccine. The second study on 114 children participants received either IPOL, OPV, or a combination of both along with DPT vaccine. . PNEUMOVAX 23 Tested on adults age 50-64yo. Subjects in each cohort were randomized to receive intramuscular injections of PNEUMOVAX 23 followed by placebo (saline containing 0.25% phenol), or placebo followed by PNEUMOVAX 23 . Prevnar 13 Tested against Prevnar unsolicited and serious adverse events were collected up to 6 months during a scripted telephone interview BEXSERO Insert mentions a trial where ; 97 participants received saline placebo, however the placebo was then followed by administration of MENVEO. Another two studies which had a PLACEBO subjects received at least 1 dose of placebo containing aluminum hydroxide. 7 days- 12 months MenQuadfi Participants received MenQuadfi or Menveo, MenQuadfi alone or MenQuadfi concomitantly with several other vaccines or U.S.-licensed comparator meningococcal vaccine, or MenQuadfi or Menomune® 7 days MENVEO participants received varying doses of MENVEO or comparator vaccines usually concomitant with other vaccine(s) In most trials, solicited local and systemic adverse reactions were monitored daily for 7 days Menactra Received Menactra or Menomune® Participants were monitored after each vaccination for 20 or 30 minutes for immediate reactions, depending on the study. Solicited injection site and systemic reactions were recorded in a diary card for 7 consecutive days after each vaccination. Participants were monitored for 28 days (30 days for infants and toddlers) for unsolicited adverse events and for 6 months post-vaccination for visits to an emergency room, unexpected visits to an office physician, and serious adverse events. M-M-R II Package insert does not mention any safety trials. There were eight trials done in the 1970s where all of the control groups received either the MMR, MR, or Rubella vaccines. A total of about 850 children received MMRII during phase 3 clinical trials GARDASIL 9 Subjects randomized to receive Gardasil 9 or Gardasil, Gardasil 9 with concomitant Menactra and Adacel, Gardasil 9 in subjects previously vaccinated with the qHPV vaccine, or Gardasil 9 concomitant administration with a non-U.S.-licensed vaccine (Repevax) . RECOMBIVAX HB Received RECOMBIVAX HB in varying dose schedules 5 days ENGERIX-B Doesn't mention any control groups 4-30 days VAQTA Describes a double-blind, placebo-controlled efficacy trial where participants received VAQTA or PLACEBO, the placebo group was actually given Aluminum Diluent. 1-14 days HIBERIX Two control groups received another Hib vaccine or DTap-Polio-Hib along with several other vaccines. Remaining clinical trials had no control group. Doesn't specifically state a follow-up period but does mention a serious adverse event that occurred 31 days after vaccination. ActHIB Received either ActHIB alone or concomitantly with other vaccines, received ActHIB vaccine or a previously licensed Haemophilus b conjugate vaccine 48 hours- 30 days INFANRIX Control groups all received Infanrix in varying dose schedules or DTP vaccine and coadministered with other vaccines 4 days- 30 days DAPTACEL In all Phase 3 Clinical Trials control groups received Daptacel or combinations of DTap or DTP vaccines sometimes concurrently with other vaccines. No placebo groups in any Phase 3 Clinical Trails were done. Follow up periods from 24 hours up to 2 months NONCLINICAL TOXICOLOGY In addition to the lack of testing for adverse events, not a single one of these vaccines have been evaluated for carcinogenic or mutagenic potential or for impairment of fertility in males. Occasionally there have been testing for impairment of fertility in females using animals. The Vaccine Inserts To Learn more Ingredients Home Page BACK TO TOP Inredients

Why I Won't Vax Home I Don't Trust Big Pharma Conflicts of Interest No Liability The Vaccine Inserts Inadequate Safety Testing Ingredients The Risks Outweigh The Benefit Unvaxxed are Healthier Decline in Illness Prior to Vaccines Vaccine Failure & Shedding Autism Vaccines Dont Cause Autism Vaccines Do Cause Autism Search Results Vaxxed vs. Unvaxxed, who is healthier? The CDC admits they have never conducted a study on fully vaccinated versus fully unvaccinated to compare overall health outcomes. The argument is that it would be "unethical" to withhold vaccines from individuals when a vaccine does exist. A strange argument considering vaccines are withheld from those involved in the safety studies done by the manufacturers prior to licensing. Except in these studies the individuals in the control groups are given the vaccine minus the antigen component or injections of toxic substances such as aluminum. (See Inadequate Safety Testing) . Also, the CDC has the medical records for millions of Americans that could be used to compare the health outcomes without having to withhold vaccines from anyone. They still refuse to do the study. ​ However, studies by independant doctors and scientists have been done. Here are some of the findings. ​ From ICAN CDC CONCEDES IT HAS NEVER CONDUCTED STUDY OF VACCINATED VS. UNVACCINATED CHILDREN On July 29, 2020, after months of false claims and objections, the CDC finally conceded that it could not find a single study comparing health outcomes between vaccinated and unvaccinated children and that it “has not conducted a study of health outcomes in vaccinated vs unvaccinated populations.” Read More From The Highwire COMPARING VACCINATED VS UNVACCINATED Dr. Stanley Plotkin is questioned under oath, about conducting a study comparing health outcomes between children receiving vaccines, and children receiving no vaccines. Watch More Data from Dr. Paul's practice, published in the International Journal of Environmental Research and Public Health showed the unvaccinated had superior health outcomes when compared to those variably vaccinated or vaccinated according to the Vaccine-Friendly Plan. Since there was essentially no child in Dr Paul's practice who was following the CDC schedule, one would have to compare these health outcomes with the going rates in America as most in the US vaccinate according to the CDC schedule. ​ Click Here For more information about Dr Paul Thomas and the Vaxxed vs Un-Vaxxed studies go to Doctorsandscience.com or "Doing this for 15 years now, I will share with you that the vaccinated kids are the sickest, the partially vaccinated kids are not as sick, and the unvaccinated kids are the healthiest." -Dr. Bob Zajac, Board-certified Pediatrician ​ ​ Find The Full Interview Here Vaxxed vs. Unvaxxed Studies What do they show? (Slides from Children's Health Defense) February 1, 2004 Frank DeStefano 1, Tanya Karapurkar Bhasin, William W Thompson, Marshalyn Yeargin-Allsopp, Coleen Boyle Age at first measles-mumps-rubella vaccination in children with autism and school-matched control subjects: a population-based study in metropolitan atlanta Vaccination before 36 months was more common among case children than control children, especially among children 3 to 5 years of age, Age at first measles-mumps-rubella vaccination in children with autism and school-matched control subjects: a population-based study in metropolitan atlanta Vaccination before 36 months was more common among case children than control children, especially among children 3 to 5 years of age, Age at first measles-mumps-rubella vaccination in children with autism and school-matched control subjects: a population-based study in metropolitan atlanta Vaccination before 36 months was more common among case children than control children, especially among children 3 to 5 years of age, 1/1 Read More November 1, 2010 Carolyn M Gallagher 1, Melody S Goodman Hepatitis B vaccination of male neonates and autism diagnosis, NHIS 1997-2002 Boys vaccinated as neonates had threefold greater odds for autism diagnosis compared to boys never vaccinated or vaccinated after the first month of life. Hepatitis B vaccination of male neonates and autism diagnosis, NHIS 1997-2002 Boys vaccinated as neonates had threefold greater odds for autism diagnosis compared to boys never vaccinated or vaccinated after the first month of life. Hepatitis B vaccination of male neonates and autism diagnosis, NHIS 1997-2002 Boys vaccinated as neonates had threefold greater odds for autism diagnosis compared to boys never vaccinated or vaccinated after the first month of life. 1/1 Read More December 1, 2018 David A. Geier,1,2 Janet K. Kern,1,2,3,* and Mark R. Geier1,2 Premature Puberty and Thimerosal-Containing Hepatitis B Vaccination: A Case-Control Study in the Vaccine Safety Datalink It was also found that the Hg exposure from Thimerosal-containing hepatitis B vaccines and the risk of being diagnosed with premature puberty occurred primarily in females where both the timing of administration and dose-dependence were important to modifying the effects observed. Premature Puberty and Thimerosal-Containing Hepatitis B Vaccination: A Case-Control Study in the Vaccine Safety Datalink It was also found that the Hg exposure from Thimerosal-containing hepatitis B vaccines and the risk of being diagnosed with premature puberty occurred primarily in females where both the timing of administration and dose-dependence were important to modifying the effects observed. Premature Puberty and Thimerosal-Containing Hepatitis B Vaccination: A Case-Control Study in the Vaccine Safety Datalink It was also found that the Hg exposure from Thimerosal-containing hepatitis B vaccines and the risk of being diagnosed with premature puberty occurred primarily in females where both the timing of administration and dose-dependence were important to modifying the effects observed. 1/1 Read More April 24, 2017 Anthony R Mawson Azad Bhuiyan Binu Jacob Brian D Ray Pilot comparative study on the health of vaccinated and unvaccinated 6- to 12- year old U.S. children With regard to acute and chronic conditions, vaccinated children were significantly less likely than the unvaccinated to have had chickenpox and pertussis but, contrary to expectation, were significantly more likely to have been diagnosed with otitis media, pneumonia, allergic rhinitis, eczema, and NDD. Pilot comparative study on the health of vaccinated and unvaccinated 6- to 12- year old U.S. children With regard to acute and chronic conditions, vaccinated children were significantly less likely than the unvaccinated to have had chickenpox and pertussis but, contrary to expectation, were significantly more likely to have been diagnosed with otitis media, pneumonia, allergic rhinitis, eczema, and NDD. Pilot comparative study on the health of vaccinated and unvaccinated 6- to 12- year old U.S. children With regard to acute and chronic conditions, vaccinated children were significantly less likely than the unvaccinated to have had chickenpox and pertussis but, contrary to expectation, were significantly more likely to have been diagnosed with otitis media, pneumonia, allergic rhinitis, eczema, and NDD. 1/1 Read More May 27, 2020 Brian S Hooker1 and Neil Z Miller2 Analysis of health outcomes in vaccinated and unvaccinated children: Developmental delays, asthma, ear infections and gastrointestinal disorders higher ORs were observed within the vaccinated versus unvaccinated group for developmental delays, asthma and ear infections. Analysis of health outcomes in vaccinated and unvaccinated children: Developmental delays, asthma, ear infections and gastrointestinal disorders higher ORs were observed within the vaccinated versus unvaccinated group for developmental delays, asthma and ear infections. Analysis of health outcomes in vaccinated and unvaccinated children: Developmental delays, asthma, ear infections and gastrointestinal disorders higher ORs were observed within the vaccinated versus unvaccinated group for developmental delays, asthma and ear infections. 1/1 Read More February 26, 2013 Elizabeth Miller 1, Nick Andrews, Lesley Stellitano, Julia Stowe, Anne Marie Winstone, John Shneerson, Christopher Verity Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis The increased risk of narcolepsy after vaccination with ASO3 adjuvanted pandemic A/H1N1 2009 vaccine indicates a causal association, consistent with findings from Finland. Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis The increased risk of narcolepsy after vaccination with ASO3 adjuvanted pandemic A/H1N1 2009 vaccine indicates a causal association, consistent with findings from Finland. Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis The increased risk of narcolepsy after vaccination with ASO3 adjuvanted pandemic A/H1N1 2009 vaccine indicates a causal association, consistent with findings from Finland. 1/1 Read More April 1, 2003 J B Classen 1, D C Classen Clustering of cases of type 1 diabetes mellitus occurring 2-4 years after vaccination is consistent with clustering after infections and progression to type 1 diabetes mellitus in autoantibody positive individuals The current findings indicate the there are also clusters of cases of T1DM occurring 2-4 years post-immunization with the pertussis, MMR, and BCG vaccine. The data are consistent with the occurrence of clusters following mumps infection and the progression to T1DM in patients with antipancreatic autoantibodies. Clustering of cases of type 1 diabetes mellitus occurring 2-4 years after vaccination is consistent with clustering after infections and progression to type 1 diabetes mellitus in autoantibody positive individuals The current findings indicate the there are also clusters of cases of T1DM occurring 2-4 years post-immunization with the pertussis, MMR, and BCG vaccine. The data are consistent with the occurrence of clusters following mumps infection and the progression to T1DM in patients with antipancreatic autoantibodies. Clustering of cases of type 1 diabetes mellitus occurring 2-4 years after vaccination is consistent with clustering after infections and progression to type 1 diabetes mellitus in autoantibody positive individuals The current findings indicate the there are also clusters of cases of T1DM occurring 2-4 years post-immunization with the pertussis, MMR, and BCG vaccine. The data are consistent with the occurrence of clusters following mumps infection and the progression to T1DM in patients with antipancreatic autoantibodies. 1/1 Read More January 8, 2019 David A Geier,1,2 Janet K Kern,1,2 and Mark R Geier1,2 A cross-sectional study of the relationship between reported human papillomavirus vaccine exposure and the incidence of reported asthma in the United States The results in this study provide the first epidemiological evidence supporting the hypothesis that reported HPV vaccine exposure significantly increased the risk of reported incident asthma. A significant association between reported HPV vaccine exposure and reported incident asthma was observed in temporal clustering, survey logistic, and survey frequency modeling even when considering covariates such as age, gender, race, and socioeconomic status. I A cross-sectional study of the relationship between reported human papillomavirus vaccine exposure and the incidence of reported asthma in the United States The results in this study provide the first epidemiological evidence supporting the hypothesis that reported HPV vaccine exposure significantly increased the risk of reported incident asthma. A significant association between reported HPV vaccine exposure and reported incident asthma was observed in temporal clustering, survey logistic, and survey frequency modeling even when considering covariates such as age, gender, race, and socioeconomic status. I A cross-sectional study of the relationship between reported human papillomavirus vaccine exposure and the incidence of reported asthma in the United States The results in this study provide the first epidemiological evidence supporting the hypothesis that reported HPV vaccine exposure significantly increased the risk of reported incident asthma. A significant association between reported HPV vaccine exposure and reported incident asthma was observed in temporal clustering, survey logistic, and survey frequency modeling even when considering covariates such as age, gender, race, and socioeconomic status. I 1/1 Read More March 17, 2017 Søren Wengel Mogensen,a,1 Andreas Andersen,b,1 Amabelia Rodrigues,a Christine S Benn,b,c and Peter Aabya,b,⁎ The Introduction of Diphtheria-Tetanus-Pertussis and Oral Polio Vaccine Among Young Infants in an Urban African Community: A Natural Experiment DTP was associated with increased mortality; OPV may modify the effect of DTP. The Introduction of Diphtheria-Tetanus-Pertussis and Oral Polio Vaccine Among Young Infants in an Urban African Community: A Natural Experiment DTP was associated with increased mortality; OPV may modify the effect of DTP. The Introduction of Diphtheria-Tetanus-Pertussis and Oral Polio Vaccine Among Young Infants in an Urban African Community: A Natural Experiment DTP was associated with increased mortality; OPV may modify the effect of DTP. 1/1 Read More April 24, 2017 Anthony R Mawson Azad Bhuiyan Binu Jacob Brian D Ray Preterm birth, vaccination and neurodevelopmental disorders: a cross-sectional study of 6- to 12-year-old vaccinated and unvaccinated children In our initial report [48], logistic regression analyses revealed that both preterm birth and vaccination (receipt of one of more of the recommended vaccines) were significantly associated with NDD after controlling for other factors, suggesting independent effects. However, in a final regression model with interaction, preterm birth combined with vaccination was associated with a 6.6-fold increased odds of NDD, suggesting a synergistic effect. Vaccination was found to be significantly and independently associated with NDD, whereas preterm birth without vaccination was not. However, vaccination coupled with preterm birth greatly increased the odds of NDD over that of vaccination alone, especially compared to being born at term and unvaccinated, suggesting that vaccination may adversely affect neurodevelopmental outcomes in preterm infants. Preterm birth, vaccination and neurodevelopmental disorders: a cross-sectional study of 6- to 12-year-old vaccinated and unvaccinated children In our initial report [48], logistic regression analyses revealed that both preterm birth and vaccination (receipt of one of more of the recommended vaccines) were significantly associated with NDD after controlling for other factors, suggesting independent effects. However, in a final regression model with interaction, preterm birth combined with vaccination was associated with a 6.6-fold increased odds of NDD, suggesting a synergistic effect. Vaccination was found to be significantly and independently associated with NDD, whereas preterm birth without vaccination was not. However, vaccination coupled with preterm birth greatly increased the odds of NDD over that of vaccination alone, especially compared to being born at term and unvaccinated, suggesting that vaccination may adversely affect neurodevelopmental outcomes in preterm infants. Preterm birth, vaccination and neurodevelopmental disorders: a cross-sectional study of 6- to 12-year-old vaccinated and unvaccinated children In our initial report [48], logistic regression analyses revealed that both preterm birth and vaccination (receipt of one of more of the recommended vaccines) were significantly associated with NDD after controlling for other factors, suggesting independent effects. However, in a final regression model with interaction, preterm birth combined with vaccination was associated with a 6.6-fold increased odds of NDD, suggesting a synergistic effect. Vaccination was found to be significantly and independently associated with NDD, whereas preterm birth without vaccination was not. However, vaccination coupled with preterm birth greatly increased the odds of NDD over that of vaccination alone, especially compared to being born at term and unvaccinated, suggesting that vaccination may adversely affect neurodevelopmental outcomes in preterm infants. 1/1 Read More August 13, 2015 Guillaume Pineton de Chambrun 1, Luc Dauchet 2, Corinne Gower-Rousseau 3, Antoine Cortot 3, Jean-Frédéric Colombel 4, Laurent Peyrin-Biroulet 5 Vaccination and Risk for Developing Inflammatory Bowel Disease: A Meta-Analysis of Case-Control and Cohort Studies Subgroup analysis for Crohn's disease (CD) and ulcerative colitis (UC) found an association between the poliomyelitis vaccine and risk for developing CD (RR, 2.28; 95% CI, 1.12-4.63) or UC (RR, 3.48; 95% CI, 1.2-9.71). Vaccination and Risk for Developing Inflammatory Bowel Disease: A Meta-Analysis of Case-Control and Cohort Studies Subgroup analysis for Crohn's disease (CD) and ulcerative colitis (UC) found an association between the poliomyelitis vaccine and risk for developing CD (RR, 2.28; 95% CI, 1.12-4.63) or UC (RR, 3.48; 95% CI, 1.2-9.71). Vaccination and Risk for Developing Inflammatory Bowel Disease: A Meta-Analysis of Case-Control and Cohort Studies Subgroup analysis for Crohn's disease (CD) and ulcerative colitis (UC) found an association between the poliomyelitis vaccine and risk for developing CD (RR, 2.28; 95% CI, 1.12-4.63) or UC (RR, 3.48; 95% CI, 1.2-9.71). 1/1 Read More June 1, 2012 Benjamin J Cowling 1, Vicky J Fang, Hiroshi Nishiura, Kwok-Hung Chan, Sophia Ng, Dennis K M Ip, Susan S Chiu, Gabriel M Leung, J S Malik Peiris Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine TIV recipients had an increased risk of virologically-confirmed non-influenza infections Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine TIV recipients had an increased risk of virologically-confirmed non-influenza infections Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine TIV recipients had an increased risk of virologically-confirmed non-influenza infections 1/1 Read More Load More BACK TO TOP Home Page Kids are Sicker Than Ever

Why I Won't Vax Home I Don't Trust Big Pharma Conflicts of Interest No Liability The Vaccine Inserts Inadequate Safety Testing Ingredients The Risks Outweigh The Benefit Unvaxxed are Healthier Decline in Illness Prior to Vaccines Vaccine Failure & Shedding Autism Vaccines Dont Cause Autism Vaccines Do Cause Autism Search Results Many illnesses were on the decline prior to widespread vaccination Most of us have heard that vaccines are one of the greatest medical advancements of modern history. It has been touted that vaccines have prevented more deaths in the last 50 years than any other advancement. Where does this information come from? More importantly, is it true? The erad ication of Polio is often the first example people use when discussing how essential vaccines are. Although, in the package insert for the Inactivated Polio Vaccine it states, "Prior to the introduction of inactivated poliovirus vaccines in 1955, large outbreaks of 5 poliomyelitis occurred each year in the United States (US). The annual incidence of paralytic 6 disease of 11.4 cases/ 100,000 population declined to 0.5 cases by the time oral poliovirus vaccine 7 (OPV) was introduced in 1961" , Polio peaked in 1952 with 57,879 cases and 3,145 deaths. In 1954 the number of polio cases dropped to 38,476 with 1,368 deaths. In two years polio cases dropped by 40% and deaths were down 78%. The following year a vaccine became available. One question that comes to mind for me is the question of correlation vs causation. We hear it all of the time when someone is injured after vaccination, "Correlation doesn't equal causation". So why is it that when its an adverse event we cannot determine causation, but when it is eradication of a disease we can? Is it possible that there could have been other factors contributing to the eradication of wild type poliovirus? What about other diseases that have seen dramatic declines? Polio April 1955 IPV vaccine was adopted throughout the United States ​ Polio types 2 and 3 have been eraticated. Type one is extremely rare. We now have more cases of vaccine derived poliovirus around the world than wild strain poliovirus. Most industrialized countries use the inactivated polio virus vaccines. Since they are not "live" vaccines they do not have the risk of Vaccine-associated Paralytic Polio. However, INACTIVATED POLIOVIRUS VACCINE DOES NOT STOP TRANSMISSION OF THE VIRUS Measles Vaccine was introduced in 1963 ​​ Approximately 400-500 people died from measles complications annually when the vaccine was introduced. That same year, 5,058 people died from asthma​ 32,465 died from diabetes mellitus 6,330 died from ulcer of the stomach 1,533 died from falling or projected objects There was a 98% reduction of Measles deaths PRIOR to the vaccine introduction ​ Numbers from the United States Office of Vital Statistics ​ View More ​ ​ Mortality Rates Drop Prior to Vaccinations A study published in 2000 in Pediatrics researchers from the Department of Population and Family Health Sciences, Johns Hopkins School of Public Health, The National Center for Health Statistics, and Centers for Disease Control and Prevention, concluded: “Thus vaccinations does not account for the impressive declines in mortality from infectious diseases seen in the first half of the twentieth century.” View More To see the listed side effects and the prelicensure safety studies check out- The Vaccine Inserts and Inadequate Safety Testing How do we explain the decline in diseases we never vaccinated against during the same time period? Contact Me Info@WhyIWon'tVax.com Submit Thanks for submitting! Home Page BACK TO TOP Vaccine Failure & Shedding

Why I Won't Vax Home I Don't Trust Big Pharma Conflicts of Interest No Liability The Vaccine Inserts Inadequate Safety Testing Ingredients The Risks Outweigh The Benefit Unvaxxed are Healthier Decline in Illness Prior to Vaccines Vaccine Failure & Shedding Autism Vaccines Dont Cause Autism Vaccines Do Cause Autism Search Results There Is No Liability For Injuries. With most products on the market consumers have the ability to bring litigation against the manufacturer if that product causes injuries. If your seatbelt is faulty and you are injured in a crash because of it, you can sue the car manufacturer for those injuries This is true for any of the products that we as consumers buy and use. Despite Bidens claim that gun manufacturers are the only industry in America that can't be sued , even they can and have been sued. ​ According to an article in Forbes, "Plaintiffs do not need to prove that the defendant acted negligently or intentionally in product liability cases. That’s because a legal doctrine called “strict liability” applies in these types of claims. Under strict liability rules, plaintiffs can prove their case and prevail in court if they simply show that the problem with the product was the direct cause of unexpected harm." In the medical industry you can sue if you are injured due to physician negligence, or faulty medical devices . For example, thousands of lawsuits have been filed against manufacturers who made metal on metal hip replacements . More than $7 Billion has been paid out in settlements for these lawsuits. If you are injured due to taking a medication you can sue the pharmacuetical companies. Currently there are over 13,000 open lawsuits in New Jersey for those injured by proton pump inhibiters such as prilosec. Claims allege that companies failed to warn consumers about the drugs potential risks of kidney failure, kidney disease , and other injuries . ​ Having the ability to file a lawsuit for injuries is important for a number of reasons. The thing that usually comes to mind for people is the financial compensation that those who are injured may need for medical bills, missed work, and compensation for pain and suffering. ​ Another important part of litigation is that it creates a system in which manufacturers must search for and produce products that are safe for their own survival. It gives them an incentive to invest into the safety of their products or face litigation that could potentially bankrupt the company. The incentive to invest money into safety is reduced greatly when a company understands that they do not have to be accountable for damages. However, a company may still consider safety testing important if they want consumers to purchase their products. With vaccines, consumers are required to take this product to enter schools and daycares. Often they must continue to get vaccines as adults to work in certain career fields. ​ By removing liability and then making the products mandatory for every person in the country we have created an extremely lucrative business model for manufacturers. There is no longer an incentive for manufacturers to invest in making their products safe. Why Is There No Liability For Vaccine Manufactureres? The National Vaccine Injury Compensation Program (NVICP) The National Vaccine Injury Compensation Program (NVICP) was establised by congress in 1986 as a no-fault alternative to the traditional legal system. Prior to this there were concerns that potential liablity for injuries caused by vaccines threatened the vaccination program and acted as a deterrant to vaccine manufacturing. The United States was facing a vaccine shortage that was thought to threaten public health. These concerns led to the establishment of The Committee on Public-Private Sector Relations in Vaccine Innovation by the Institute of Medicine in 1983. The committee was asked to do a comprehensive study of vaccine research and development, production and supply, and utilization. ​ Their report and reccommendations were published in 1985. You can find that full report HERE. In their report they state that, "A manufacturer is not liable for harm caused by a nondefective product due to its inherent or unavoidable dangerousness . Thus, if a properly manufactured vaccine will cause harmful side effects in some portion of the recipient population, the manufacturer of the vaccine is not liable for those side effects." They go on to state that some products are " Unavoidably unsafe products. There are some products which, in the present state of human knowledge, are quite incapable of being made safe for their intended and ordinary use. " The report notes that those injured by vaccines should recieve compensation and that the traditional legal system can be complex, expensive and time consuming. Therefore, the committee recommends the development of a compensation program where claims should be processed without regard to "fault". They recommend the establishment of a schedule of events for which scientific evidence indicates a plausible association with vaccination. ​ The goal of the NVICP was to encourage investment in vaccine development and manufacturing and to compensate those who are injured in a timely mannor. The program seems to have been effective at encouraging vaccine development. With the threat of liability off the table the vaccination program has exploded. In 1986 children recieved 12 doses of 8 vaccines. In 2023 we are up to 58 doses of 18 vaccines from birth-18 years, plus 2 injections for 4 vaccines in-utero. This chart from Children's Health Defense shows vaccine schedules from 1986 compared to 2019. We have since added 3 doses of Covid-19 vaccinations to the schedule. However, the program has not been as successful when it comes to making sure those who are injured are compensated for their injuries. The program has a table of covered vaccines and injuries that will qualify for compensation if they fall within a certain time frame of being vaccinated. For injuries that are not listed on the table the burden of proof lies with the petitioner. The program also has a very strict time limit of 3 years from the time of injury to file a claim. Since 1988 there have been 25,961 claims filed and 9,664 of those were compensated. Considering there have been 2,439,553 reports of injury to VAERS following vaccination , and that a report by Harvard Pilgrim Health noted, "fewer than 1% of vaccine adverse events are reported" to VAERS , there seems to be a very small number of individuals with injuries actually filing a claim with the NVICP. ​ (See What Is VAERS?) ​ The program has also not been a timely process for petitioners. A report from the U.S. Government Accountability Office looked at the data for claims filed between 1999-2014 and found that most claims took multiple years to process. View More "Every year, a number of children are seriously injured by adverse reactions to vaccines. When such a tragedy befalls a family, they are faced with devastating emotional and financial consequences. As the devastation of adverse reactions can lead to paralysis, permanent disability and death, families without adequate insurance can face enormous expenses, including residential care, therapy, medical equipment, and drugs." ​ -COMMITTEE ON GOVERNMENT REFORM, SIXTH REPORT Public Readiness and Emergency Preparedness Act (PREPA) The Public Readiness and Emergency Preparedness Act (Prep Act or PREPA) was enacted by Congress in 2005. Health & Human Services describes the PREP Act on their website , "The Public Readiness and Emergency Preparedness Act (PREP Act) authorizes the Secretary of the Department of Health and Human Services (Secretary) to issue a PREP Act declaration. The declaration provides immunity from liability (except for willful misconduct) for claims: of loss caused, arising out of, relating to, or resulting from administration or use of countermeasures to diseases, threats and conditions determined by the Secretary to constitute a present, or credible risk of a future public health emergency to entities and individuals involved in the development, manufacture, testing, distribution, administration, and use of such countermeasures A PREP Act declaration is specifically for the purpose of providing immunity from liability, and is different from, and not dependent on, other emergency declarations." ​ Immunity means that courts must dismiss claims brought against any entity or individual covered by the PREP Act. Claims that courts must dismiss include claims for any loss that is related to any stage of design, development, testing, manufacture, labeling, distribution, formulation, labeling, packaging, marketing, promotion, sale, purchase, donation, dispensing, prescribing, administration, licensing or use of a countermeasure recommended in a Declaration. This includes, but is not limited to, claims for: death; physical, mental, or emotional injury, illness, disability, or condition or fear of any such injury, illness, disability, or condition; any need for medical monitoring; or property damage or loss, including business interruption loss. The only exception is for claims of willful misconduct. ​ From the U.S. Department of Health & Human Services A Declaration may provide liability immunity for covered persons. Covered persons may include, at the Secretary’s discretion: Manufacturers of countermeasures; Distributors of countermeasures; Program planners , i.e., individuals and entities involved in planning, administering, or supervising programs for distribution of a countermeasure (e.g., State or local governments, Indian tribes, or private sector employers or community groups that establish requirements or provide guidance, technical or scientific advice or assistance, or provide a facility); Qualified persons, i.e., persons who prescribe, administer, or dispense countermeasures such as healthcare and other providers or other categories of persons named in a Declaration, e.g., volunteers; Officials, agents, and employees of any of these entities or persons; and The United States. ​ A “covered countermeasure” may be: A qualified pandemic or epidemic product ; A security countermeasure ; An unapproved drug , biological product , or device used under an Emergency Use Authorization (EUA) issued by FDA; An approved drug , biological product , or device used pursuant to Federal law in conditions that are in consistent with its approval ; or An unapproved drug , biological product , or device , or an approved drug, biological product , or device intended for an unapproved use, that is intended for emergency use and shipped and held by a government agency or someone working on that agency’s behalf for use only when that use is authorized. ​ ​ The PREP Act states that those who are seriously injured, described as an injury that warranted hospitalization (whether or not the person was actually hospitalized) or that led to a significant loss of function or disability, by a declared countermeasure may file a claim with the Countermeasures Injury Compensation Program (CICP) within one year of the injury. ​ " If no funds have been appropriated to the compensation program, or the Secretary does not make a final determination on the individual’s request within 240 days, or the individual decides not to accept the compensation, the injured individual or his representative may pursue a tort claim in the United States District Court for the District of Columbia, but only if the claim involves willful misconduct and meets the other requirements for suit under the PREP Act . If the individual accepts compensation from the CICP, or if there is no willful misconduct, the individual does not have a tort claim that can be filed in a United States Federal or a State court. Any award is reduced by public or private insurance or worker’s compensation available to the injured individual. Awards for non-economic damages, such as pain, suffering, physical impairment, mental anguish, and loss of consortium are also limited ." ​ CICP may compensate for medical expenses, lost employment income, and survivors benefits. However, it is a last resort and will only pay for expenses that are not compensated by other means such as health insurance and workmans comp. Unlike the NVICP, the CICP will not cover lawyer fees. ​ Since 2010 there have been only 30 claims compensated through the CICP CICP Data for Fiscal Years 2010 – 2023 (As of March 1, 2023) Total CICP Claims Filed: 11,765 Pending Review or In Review: 10,629 Decisions: 1,136 Claims Found Eligible for Compensation: 61 Claims Compensated: 30 Claims Pending Benefits Determination: 21 Claims with No Eligible Reported Expenses: 10 Denied: 1,075 Requested Medical Records Not Submitted: 182 Standard of Proof Not Met and/or Covered Injury Not Sustained: 324 Missed Filing Deadline: 248 Not CICP Covered Product/Not Specified: 321 There Is Also No Mandated Reporting For Injuries In a research project conducted by Harvard Pilgrem Health over a span of three years and funded by a grant from Health and Human Services, it was noted that "fewer than 1% of vaccine adverse events are reported. " The team at Harvard Pilgrem Health developed a way to electronically monitor medical records and notify physticians of possible adverse events following reciept of vaccinations. This would prompt the physician to review the records and submit the event to the VAERS system, along with any optional notes or to note in the record reasons for not submitting to VAERS. The team concludes that after three years of collecting data and development of the automated system they were unable to move forward with implementing the program, "Unfortunately, there was never an opportunity to perform system performance assessments because the necessary CDC contacts were no longer available and the CDC consultants responsible for receiving data were no longer responsive to our multiple requests to proceed with testing and evaluation." More information can be found HERE One report describes VAERS as a spontaneous surveillance system and explains, " Spontaneous surveillance means that no active effort is made to search for, identify and collect information, but rather information is passively received from those who choose to voluntarily report their experience. Therefore, VAERS relies on the intuition and experience of healthcare professionals in particular, but likewise for patients, parents and caregivers, to recognize and report unusual or unexpected events following vaccination or suspected vaccine safety problems. " This same report notes that, "During 2011-2014, VAERS averaged around 30,000 U.S. reports annually, with 7% classified as serious." If VAERS is only representiong 1% of adverse events that would mean the number of actual adverse events during that 3 year period was closer to 3,000,000 annually with about 210,000 a year being serious. Some might say that is a small number compared to the number of vaccine doses administered each year, but when its your child who is injured the number isn't small at all. Another important point to consider is "Vaccines are generally given to healthy individuals to prevent disease, whereas drugs are primarily given for treatment of illness. Sick patients, or parents of sick children, might be more willing to accept safety risks of drugs used to treat illnesses compared to vaccines used to prevent possible future illnesses." 210,000 serious injuries a year starts to seem like a lot when you consider many of these injuries happened in perfectly healthy children. Looking back on our own personal experience my son was seen in urgent care 3 times in the 30 days following his first round of vaccines. None of these visits were reported to VAERS. Not one of the doctors, nurses, or other medical professionals (such as those at the WIC office or our public healt h nurse who came out to visit us weekly) ever mentioned that vaccines could have been related to the issues we were having. Sadly, I was unaware that it was even possible for vaccines to cause these problems. Then dealing with a sick baby who would not eat or sleep and screamed non-stop, I was sleep deprived and stressed out and not able to see clearly the connection that is so obvious to me when looking back. Whether is was caused by the vaccine or not those urgent care visits should have been reported to VAERS so that it could be used to look for signals. If there are a high number of urgent care visits with similar complaints following the same vaccinations that would raise a flag for our regulatory agencies to look at it further. If things are not reported then they can't find possible connections. Home Page BACK TO TOP The Vaccine Inserts